Geriatric Neurology by jianghongl


									                  Volume 91   No. 5   May 2008

Geriatric Neurology
                                                                      Medicine                                    Health
UNDER THE JOINT                                                                                                                                                       VOLUME 91 N O. 5 May 2008
The Warren Alpert Medical School of
  Brown University
  Eli Y. Adashi, MD, Dean of Medicine
  & Biological Science
                                                    RHODE ISLAND                                             PUBLICATION OF THE RHODE ISLAND M EDICAL SOCIETY
Rhode Island Department of Health
  David R. Gifford, MD, MPH, Director
Quality Partners of Rhode Island
  Richard W. Besdine, MD, Chief                     COMMENTARIES
  Medical Officer
                                                    126          Introduction to Geriatric Neurology Issue
Rhode Island Medical Society                                          Joseph H. Friedman, MD
  Nick Tsiongas, MD, MPH, President
                                                    126          Some Thoughts On Ethical Guidelines for the Neurology-Impaired Elderly
EDITORIAL STAFF                                                     Stanley M. Aronson, MD
Joseph H. Friedman, MD
Joan M. Retsinas, PhD                               CONTRIBUTIONS
   Managing Editor
                                                    SPECIAL ISSUE: Geriatric Neurology
Stanley M. Aronson, MD, MPH
   Editor Emeritus                                  129          Aging of the Human Nervous System: What Do We Know?
                                                                     Richard W. Besdine, MD, FACP, AGSF, and Difu Wu
Stanley M. Aronson, MD, MPH                         132          Mild Cognitive Impairment, Healthy Aging and Alzheimer’s Disease
Jay S. Buechner, PhD                                                 Chuang-Kuo Wu, MD, PhD
John J. Cronan, MD
James P. Crowley, MD                                134          Gait In the Elderly
Edward R. Feller, MD                                                 Joseph H. Friedman, MD
John P. Fulton, PhD
                                                    136          Parkinson’s Disease In the Elderly
Peter A. Hollmann, MD
Sharon L. Marable, MD, MPH                                           Marie-Hélène Saint-Hilaire, MD, FRCPC
Anthony E. Mega, MD                                 138          Epilepsy In the Elderly
Marguerite A. Neill, MD                                              Amanda M. Diamond, MD, and Andrew S. Blum, MD, PhD
Frank J. Schaberg, Jr., MD
Lawrence W. Vernaglia, JD, MPH                      142          Peripheral Neurology: Speech Concerns In the Elderly
Newell E. Warde, PhD                                                 George M. Sachs, MD, PhD
OFFICERS                                            144          Sleep Disorders In the Elderly
Nick Tsiongas, MD, MPH                                               Jean K. Matheson, MD
                                                    146          Driving Safety Among Older Adults
Diane R. Siedlecki, MD
                                                                     Melissa M. Amick, PhD, and Brian R. Ott, MS
Vera A. DePalo, MD                                  148          Geriatric Neurorehabilitation In the New Millenium
  Vice President                                                     Stephen T. Mernoff, MD
Margaret A. Sun, MD
Mark S. Ridlen, MD                                  COLUMNS
  Treasurer                                         151          HEALTH BY NUMBERS – The Value Equation: Costs and Quality of Rhode
Barry Wall, MD
                                                                     Island’s Health Plans
  Immediate Past President
                                                                     Bruce Cryan, MBA, MS
DISTRICT & COUNTY PRESIDENTS                        153          PUBLIC HEALTH BRIEFING – Rhode Island Leads In Regulating Office-Based
Geoffrey R. Hamilton, MD
  Bristol County Medical Society
                                                                     Cosmetic Surgery
Herbert J. Brennan, DO                                               Shaun Najarian
  Kent County Medical Society                       154          POINT OF VIEW – Creative and Sensory Therapies Enhance the Lives of
Rafael E. Padilla, MD                                                People With Alzheimers
  Pawtucket Medical Association
Patrick J. Sweeney, MD, MPH, PhD
                                                                     John Stoukides, MD
  Providence Medical Association                    155          PHYSICIAN’S L EXICON – The Prefixes of the Past
Nitin S. Damle, MD                                                   Stanley M. Aronson, MD
  Washington County Medical Society
Jacques L. Bonnet-Eymard, MD                        155          Vital Statistics
  Woonsocket District Medical Society               156          May Heritage
Cover: “Red Blooms in Spring,” watercolor, by
Theresa Aiello. Ms. Aiello, age 91, painted Red
Blooms in Spring as part of the art program at
the Hope Alzheimer’s Center. She has been par-
ticipating at the Center since 2004 and lives in    Medicine and Health/Rhode Island (USPS 464-820), a monthly publication, is owned and published by the Rhode Island Medical Society, 235
North Providence.                                   Promenade St., Suite 500, Providence, RI 02908, Phone: (401) 331-3207. Single copies $5.00, individual subscriptions $50.00 per year, and $100
The Hope Alzheimer’s Center specializes in caring   per year for institutional subscriptions. Published articles represent opinions of the authors and do not necessarily reflect the official policy of the Rhode Island
                                                    Medical Society, unless clearly specified. Advertisements do not imply sponsorship or endorsement by the Rhode Island Medical Society. Periodicals postage
for people with memory loss and helping families
                                                    paid at Providence, Rhode Island. ISSN 1086-5462. POSTMASTER: Send address changes to Medicine and Health/Rhode Island, 235 Promenade St.,
keep their loved ones living at home. For more      Suite 500, Providence, RI 02908. Classified Information: RI Medical Journal Marketing Department, P.O. Box 91055, Johnston, RI 02919,
information on the center, contact Cyndi Forcier,   phone: (401) 383-4711, fax: (401) 383-4477, e-mail: Production/Layout Design: John T                eehan, e-mail:
phone 946-9220.
                                                                                                                                                         VOLUME 91                   NO. 5           MAY 2008

      Introduction To Geriatric Neurology Issue

      Age takes a toll. Mathematicians’ best        normal. Essential tremor in an elderly               In this issue we grapple with the neu-
      work is behind them by their late twen-       person, for example, can be indistinguish-      rology of aging. Excepting pediatricians,
      ties, if not earlier. Chess champions are     able from Parkinson’s disease, but the          we all deal with the elderly, and neuro-
      never elderly. No athletic records are held   prognosis and treatments are quite dif-         logical problems become, like all other
      by the elderly. Yet some people get wiser.    ferent. Gait disorders in an elderly per-       problems, increasingly common. Many
      The great novels are products of skills       son with widespread arthritis, multiple         non-neurologists are neurology-phobic
      honed with time, wisdom and experience,       joint replacements and diabetic neuropa-        and, because neurology used not to be a
      and, clearly a different sort of creativity   thy, are often impossible to accurately clas-   treatment oriented discipline, often tend
      than required in mathematics and chess.       sify, other than with the highly accurate       to overlook neurologic problems, or else
      Our brains start to lose neurons in our       designation, “multifactorial,” which may,       consider them part of the process of nor-
      twenties. As an elderly Houston Merritt,      or may not be helpful to all concerned.         mal aging (“once you’re 80 everyone has
      MD, the author of one of the standard               In the course of my 25 years of prac-     tremors or falls down once in a while”).
      American neurology texts, and a giant of      tice I have personally witnessed the as-        In this issue we hopefully are “user
      twentieth century neurology, once com-        tounding increase in the number of eld-         friendly,” and help you in your day to
      mented, “when it’s very quiet, I can some-    erly and very elderly patients I treat. In a    day care of the elderly.
      times hear the splash a dying neuron          recent review I learned that I have cared            These articles are summaries of a day
      makes as it falls into the lacunar lakes in   for 43 patients with Parkinson’s disease        long course on geriatric neurology given
      my brain.”                                    over the age of 90! Twenty years ago I          in Providence on Nov 3, 2007.
            In the 1930’s the great British neu-    probably hadn’t ever seen a PD patient
      rologist, MacDonald Critchley, pub-           of that advanced age. As we all know, this                     – JOSEPH H. FRIEDMAN, MD
      lished a series of papers pointing out that   is a mixed blessing. In Gulliver’s Travels,
      aging produced, as a normal conse-            one of the lands Gulliver visits has a small    Disclosure of Financial Interests
      quence, many of the features we identify      group of people who are immortal. He                 Joseph Friedman, MD, Consultant: Acarta
      as pathological in Parkinson’s disease. Yet   thinks this a great miracle but is informed     Pharmacy, Ovation, Transoral; Grant Research
      these changes are not considered patho-       that it is considered a curse because the       Support: Cephalon, Teva, Novartis, Boehringer-
      logical. Perhaps they will be sometime        people are not free of the diseases of ag-      Ingelheim, Sepracor, Glaxo; Speakers’ Bureau:
      soon. These “normal” changes often pro-       ing, thus becoming crippled and de-             AstraZeneca,Teva,Novartis,Boehringer-Ingelheim,
      duce clinical challenges for physicians       mented, and never granted the freedom           GlaxoAcadia, Sepracor, Glaxo Smith Kline
      trying to distinguish pathological from       of death.

                         Some Thoughts On Ethical Guidelines for the
                               Neurologically-impaired Elderly
      There is a widely accepted Inuit tale [denied as factual by many           There is little debate that a patient who is both elderly and
      anthropologists] that when their frail elders reach a point of        neurologically impaired is effectively marginalized, certainly by
      senility requiring active nursing care, or when the food supply       contemporary society – and sometimes even by members of the
      of their community becomes perilously low, the demented el-           healing community. Many patients with organic disabilities have
      ders are reverently placed upon an ice-flow to drift away into        a way of rehabilitating themselves; less so, though, for those with
      the Eskimo equivalent of oblivion.                                    the loss of neural or cognitive function, thus making the elderly
           Two current social and geophysical realities have altered        who are paralyzed or the elderly who are demented vulnerable
      this aboriginal scenario: first, the intrusion of earnest ethical     to a more stringent standard of appraisal – outliers, perhaps – in
      debate regarding the extent and merit of care for the elderly         the calculus of care for the elderly American citizen.
      who are neurologically impaired [such care ranging from the                In an appraisal of moral norms and moral hopes in the
      very best technologically to utter abandonment]; and second,          field of geriatric neurology, there are substantially more ques-
      with the indisputable acceleration of global warming, there is        tions than there are confident answers or even flexible guide-
      the diminution in the number and survivability of arctic ice-         lines. Geriatric neurology, particularly as it pertains to the de-
      flows.                                                                mented elderly, presents an array of incorrigible problems
readily distinguishable from the other sub-disciplines of medi-          formally sensitized and educated in distinguishing between a
cine by the frequent use of such alien words as triage, eco-             demented elderly wandering the streets and an inebriated per-
nomic utilitarianism, equity, social justice, palliation, hospice        son wandering the same thoroughfares.
care and the right to die; and the use of such needlessly inflam-             Years later the report was reviewed and our recommenda-
matory words as euthanasia and “pulling-the-plug.”.                      tions [regarding the assignment of state hospital beds for those
     An ethical consideration - with any medical dilemma in-             with advanced dementia] were accepted.
volving the elderly - certainly demands that a few basic ques-                There is little debate now that organic dementia is more
tions be confronted:                                                     than a medical problem; more than a public health problem
                                                                         draining much of this nation’s health-care budget; and certain
1. Does the patient’s age, per se, play any conscious role in deter-     a compelling nightmare for those responsible for planning for
   mining the employment [or abandonment] of any therapeu-               this nation’s future medical needs.
   tic intervention ? Should it ? Is there such a thing as age-related        In 1950, 4% of this nation’s GNP was invested in health
   rationing of institutional care or medical interventions?             care. By 1994, this had risen to 14%; it is now verging upon
2. Rewording the question, does age-conscious triage be-                 20% - and rising. A decade ago this government was spending,
   come operative in elderly, neurologically impaired patients           on average, $14,000 per year on each elderly American under
   more so than in orthopedically-impaired elderly ?                     the Medicare program; it is now approaching $20,000. And as
3. Are stroke victims, beyond the age of 80, viewed differently          the nation – particularly its old-old segment – grows in number,
   than dementia victims of similar age ? Rewording this ques-           and as the number of Americans burdened with dementia of
   tion: Does future prognosis play a role in determining present        the Alzheimer type increases exponentially, the cost of protect-
   medical intervention ? Does the projected lifespan for the            ing and caring for these encumbered patients will grow at an
   patient influence the type and intensity of the therapy?              alarming rate. Finally these staggering costs will overweigh the
4. Concerning diagnostic or clinical interventions of doubt-             humanitarian beliefs in this country and—barring a medical
   ful merit, whose vision [or will] prevails ? The patient ? The        miracle in discovering ways to prevent or cure the organic
   patient’s assigned surrogate ? The family ? Clergy ? Physi-           dementias—the rationing of care will become inevitable.
   cian ? And when differences arise, whose decision prevails?                What may we expect in an elderly person with long-stand-
5. Are there occasions when palliation replaces active inter-            ing dementia? At best a stabilization of the sense of personal
   vention ? And what are the thresholds when active inter-              identity and cognitive awareness. Visitors, whose visits tend to
   vention gets replaced?                                                be brief and cursory, may comment that they experience no
6. When is the patient’s plea to die listened to and acted upon?         communication with their sick relatives, that they are no longer
                                                                         recognized by the demented patients and view them as one
      Before confronting these questions, let us consider a bit of       step removed from a persistent vegetative state. Nursing aides
local history as well as certain demographic verities. In 1984,          however, may attest to a measurable degree of communication
Rhode Island’s General Assembly convened a task force as-                as well as preservation of some “selfness.” To exploit a com-
signed with the problem of determining the extent to which               mon cliché, is the cognitive cerebrum half-full or half-empty?
patients with enduring dementia imperiled the health care sys-                Despite the notable advances in biotechnology in recent
tem of the state. Our first task was to define the clinical state of     years, and despite some unsubstantiated claims that the progress
dementia [using standard criteria of duration of dementia, type          of Alzheimer’s disease may be slowed by certain medications,
and extent of memory loss, degree of disorientation, loss of so-         the professional care of such patients remains largely in the
cial judgment, insight and the capacity to fulfill the minimal           domain of care-takers such as nurses. Physicians continue to
tasks of daily living]; then to survey each of the 107 registered        play an identifiable role in initiating more aggressive therapies
nursing homes in the state to determine how many of their                for such complications as decubitus ulcers, opportunistic in-
residents could be identified as organically demented; and fi-           fections and renal or cardiopulmonic failure. What guidelines
nally, to extrapolate from these data to estimate the total num-         may then be established for a disease that is both progressive—
ber of the demented within the state [in hospitals, nursing homes        often relentlessly so—and without effective therapy?
and private homes]. We did not distinguish between dementia                   Certainly, comfort measures, good nursing, pain-control
of the Alzheimer’s type, multi-infarct dementia, Lewy body               if needed and scrupulous attention to hygienic needs. But
dementia or other dementias such as the heritable ones as those          beyond these interventions, what then? Specifically, when in
associated with Huntington’s disease.                                    the course of this ailment might discussions be begun about a
      We concluded, conservatively, that in 1985 there were about        regime confined to palliative care? Daniel Callahan has sug-
10,000 persons with dementia in a state population of about              gested three standards to observe in such trying situations:
one million souls [about 1% of Rhode Island.] We presented
our data to the State legislature. The first response to our oral        1. No one should, in the modern world, have to live longer
presentation was: “Never heard of Alzheimer’s disease. What is it           in the advanced stages of dementia than he or she would
? Something new like AIDS?” Our demographic data—and                        have in a pre-technologic era.
our projections into the 21st Century—were treated with a com-           2. The likely deterioration in individuals with advanced de-
bination of wry amusement and skepticism. And, accordingly,                 mentia should lead to a shift in the usual standard of treat-
our recommendations were largely ignored—although the State                 ment: that of stopping rather than continuing or extend-
police did take to heart our recommendation that the police be              ing treatment.
                                                                                                        VOLUME 91      NO. 5    MAY 2008
      3. For the medical profession, there is as great an obligation              We, as a society, must confront the realities of a near-fu-
         to avoid a lingering, painful or degrading death as there          ture in which an avalanche of impaired elderly with dementia
         is to promote health and life.                                     will inundate the health care industry and its inpatient institu-
                                                                            tions, places ranging from nursing homes to tertiary care hos-
            Which avoids the crucial question: What clinical features       pitals.
      forewarn the attending physician that the time has arrived to               Our health-care professions are about to be overwhelmed by a
      warrant cessation of interventions beyond those designed for          tragedy of human aging called dementia. We assemble earnest pa-
      comfort, cleanliness, adequate hydration and freedom from             pers such as this, make honorable declarations, admonish ourselves
      pain ? The single criterion continues to be whether there is          for alleged insensitivities, atone for our past negligences, pay obei-
      any residual sense of conscious selfness in the patient, any aware-   sance to the ethical standards of our vocations, recall oaths to do no
      ness—even if only episodic—of himself or herself. Just as fam-        wrong, identify the physical needs of the demented, decry the in-
      ily members, visiting briefly, may observe nothing beyond a           sensitive insurance industry for wanting to set explicit thresholds for
      vegetative existence, so too with the physician visiting for a few    triage – but rarely do we listen to the secular voices of the demented.
      moments. The insight into the patient’s sense of social identity      Let me end with a poem by Maya Angelou, a poem that says so
      may come, more commonly, from the nurse or aide who feeds,            much more than any powerpoint presentation might convey:
      bathes and interacts regularly with the patient.
            The thoughts, wishes and religious observances of the fam-           The print is too small, distressing me.
      ily, the views of the concerned clergy must be listened to, but            Wavering black things on the page.
      not heeded blindly. The wishes of the patient remains para-                Wiggling polliwogs all about.
      mount, whether expressed in an advance directive, in a will or             I know its my age.
      in any reliable document; or, expressed orally during his or her           I’ll have to give up reading.
      current institutionalization.
                                                                                 The food is too rich, revolting me.
                               •      •       •                                  I swallow it hot or force it down cold,
                                                                                 And wait all day as it sits in my throat.
                                                                                 Tired as I am, I know I’ve grown old.
                                                                                 I’ll have to give up eating.

                                                                                 My children’s concerns are tiring me.
                                                                                 They stand at my bed and move their lips,
                                                                                 And I can’t hear one single word.
                                                                                 I’d rather give up listening.

                                                                                 Life is too busy, wearying me.
                                                                                 Questions and answers and heavy thought.
                                                                                 I’ve subtracted and added and multiplied.
                                                                                 And all of my figuring has come to naught.
                                                                                 Today I’ll give up living.

                                                                                                                – STANLEY M. ARONSON, MD

                                                                            Disclosure of Financial Interests
                                                                            Stanley M. Aronson, MD, has no financial interests to disclose.


  Aging of the Human Nervous System: What Do We Know?
                                        Richard W. Besdine, MD, FACP, AGSF, and Difu Wu

LEARNING OBJECTIVES                                                       quence of the pure aging syndrome. The resulting reduced ca-
     Demonstrate the ability to identify and use in clinical care:        pacity to maintain homeostasis during stress often leads to early
                                                                          and unexpected decompensation under a variety of mild homeo-
1. Nervous system changes with age                                        static perturbations. It is the superimposition of acute illness or
2. Differences between pure aging in the NS and the ef-                   drug toxicity upon the pure aging syndrome that results in
   fects of common diseases                                               “homeostenotic” organ crises. There is no better example than the
3. Age-related changes in key domains:                                    extraordinary vulnerability of elders to delirium when they are
          a. Cognition/Memory                                             stricken with many illnesses or adverse drug effects.
          b. Special senses                                                     Once the changes of pure aging are understood, the im-
          c. Strength                                                     pact, evaluation and management of superimposed disease in
          d. Balance                                                      older adults can be appreciated. The complexity of these in-
          e. Somatic sensation                                            teractions of disease and aging defines the field of geriatrics.
                                                                          Nowhere are these interactions more complex and potentially
OVERVIEW: AGING         IN   21ST CENTURY AMERICA                         confusing for the clinician than in the nervous system.
     Americans have gained >25 years of average life expectancy
during the 20th century, and there is no evidence of slowing in the       I. COGNITION
21st. Although clinical and public health interventions have al-               A. Attention – There is a mild decline in overall accu-
lowed gains in healthy life expectancy (average age of disability         racy, beginning in the 60s that progresses slowly, but sustained
onset) to keep pace with the striking gains in longevity, the sheer       attention very good in healthy older adults. Older adults are
numerical increases of older persons portend a burden of disease          more easily distracted, especially if irrelevant information is
and disability that will overwhelm the social and financial capacity      presented concurrent with important material.
of our technologically advanced society to manage older persons’               Clinical point: When giving crucial information to older
health and health care. And Congress dabbles by trying to trim 1-         patients, stick to core data, repeat it and write it down.
2% from the current Medicare growth rate. The tools to meet
these care needs are biomedical science coupled with strategic                B. Learning and memory
changes in health care delivery for the very old and vulnerable;              1. Sensory memory is the earliest stage (visual, auditory,
neurological problems of aging are a major contributor to the                    tactile); it is inherently unstable and decays rapidly.
morbidity and healthcare costs for older adults.                                 There is no age-related change.
                                                                              2. Primary (short-term) memory is the stage after trans-
NEUROLOGY       OF   AGING                                                       fer of sensory memory. There is no loss with age.
      There is no greater fear among most Americans than loss of              3. Secondary (long-term) memory persists for hours, days
brain function – whether the loss of the very persona from demen-                and years. There is a decline with age, mostly in free
tia (usually Alzheimer’s disease), the multiple other neurodegenerative          recall; recognition is well preserved. The universal tem-
conditions that are increasingly common with age (e.g., Parkinson’s              porary decline in the ability to retrieve names generally
disease, ALS) or the sudden devastation of stroke.                               begins early in middle age, and worsens over time. The
                                                                                 lost name is almost always retrieved soon after the epi-
WHAT     IS   OBLIGATORY     WITH   AGING?                                       sode. This phenomenon is not predictive of any
      As we age, many neurological disorders become common. What                 neurodegenerative disorder (e.g., Alzheimer’s disease).
are the changes occurring in the nervous system that are inevitable           4. Encoding strategies help retrieval - mnemonics, men-
with age in the healthiest adults, even those who exhibit all known              tal hierarchies, clusters—but they are used less by older
risk-reducing behaviors? Using the term Pure Aging Syndrome                      persons. Training gives long-lasting improvements.
makes clear that no disease, environmental, life style or behavioral          5. Distraction interferes with learning more in older
risk factor plays a role in the change. These are brain function                 persons than in young.
changes that are inevitable, irreversible with current technology, and        6. Clinical point: Give instructions directly and simply,
while mostly decremental, do not cause symptoms on their own.                    encourage encoding strategies, refer to reputable
Although there is much in the literature about decrease in brain size            memory training.
and weight with age, secular trends of increasing size of humans
make such conclusions from cross-sectional data hazardous. In ad-               C. Language – Vocabulary increases well into the 50s
dition, only in the past 50 years have large numbers of healthy adults    and 60s, and shows no decline with age in those who continue
survived into old age. Accordingly, great caution should be taken         to be engaged in complex language use. Similarly, syntactic
when concluding that brain shrinkage is due to age alone.                 skills – the ability to combine words in meaningful sequences –
      A useful concept is “homeostenosis,” the progressive restric-       show no decline with pure aging.
tion of physiologic reserve capacity in organ systems as a conse-
                                                                                                          VOLUME 91      NO. 5    MAY 2008
            D. Intelligence, as measured by the Wechsler Adult In-            II. STRENGTH
      telligence Scale, declines with age, but the biggest, earliest losses       A. Muscle – Disuse and disease, as in many systems, are
      were reported in flawed studies. Cohort differences under-              major confounders of age effect.
      mined these cross sectional studies, causing selection bias re-             1. Age-related changes include loss of muscle mass,
      garding education, gender, race, occupation and income. Sum-                   though strength loss can be relatively preserved by
      mary scores of “intelligence” per se are less useful in adults.                exercise. Reduction in muscle fiber size occurs pri-
      Measuring specific intellectual functions has become usual.                    marily in Type II (‘fast’) fibers, which are highly
                                                                                     anaerobic; Type I (‘slow’) fibers, which are aerobic,
           1. Crystallized intelligence (learning and experience) re-                tend to retain their size during aging.
              mains stable or improves with age until the late 70s                2. Muscle wasting in frail older persons, a disorder
              or beyond, especially in those who remain healthy                      known as sarcopenia, leads to higher incidence of
              and engaged in cognitively demanding activities.                       falls and fractures and functional decline.
           2. Fluid intelligence (problem-solving with novel ma-
              terial requiring complex relations) declines rapidly                  B. Spinal reflex changes include decline in amplitude
              after adolescence.                                              of the spinal stretch reflex with normal aging, due in part to
           3. Perceptual motor skills (timed tasks) decline with age.         stiffness of tendons.

      Special Senses                                                               D. Motor cortex changes with age include decrease in
           E. Vision                                                          the number of neurons and synapses; one hypothesis is that
           1. Pure aging includes decline in accommodation (pres-             disuse atrophy occurs, arguing for a “use it or lose it” construct.
              byopia), low-contrast acuity, glare tolerance, adapta-
              tion, color discrimination and attentional visual field.             E. Basal Ganglia – Age-related changes in the striatum
              Changes occur in components of the eye itself and               include decline in dopamine D1 receptor density in the cau-
              in central processing. These numerous changes af-               date and putamen. Age-related loss of dopamine neurotrans-
              fect reading, balance and driving, but compensatory             mission may play a role in vulnerability of older adults to ex-
              glasses and behavior can maintain safety.                       trapyramidal disorders. In the substantia nigra, pigmented
           2. The common eye diseases in old age (glaucoma, macu-             neurons drop out; their loss is associated with motor dysfunc-
              lar degeneration, cataracts, diabetic retinopathy) are          tion, including bradykinesia, stooped posture and gait distur-
              superimposed upon these pure aging changes.                     bance. These aging changes mimic parkinsonian features, and
                                                                              may account for the increase in prevalence of PD with age.
           F. Hearing
           1. Conductive and sensory hearing losses (presbycusis)             III. BALANCE
              occur with age; losses are primarily high tones, mak-                 Balance function declines with increasing age, but is rarely
              ing consonants in speech difficult to discriminate.             the sole cause of falls in older persons. Strength, cerebellar integ-
           2. Although impairment is defined as an auditory threshold         rity, vestibulo-cochlear function, hearing and vision all play a role
              greater than 25 decibels, the nearly half of Americans >        in maintaining balance. Degeneration of the otoconia (granules
              80 who don’t reach the clinical threshold of 25 decibels        of the otolith) is a mechanism for vestibule-cochlear decline with
              still have diminution in acuity – pure aging effects.           aging. Many diseases affect the vestibular portion of the 8th N,
           3. Consequences include difficulty in localizing sound             and it is also sensitive to drugs. Finally, proprioception also con-
              and understanding speech, usually accompanied by                tributes to maintenance of balance. Muscle spindle and mechano-
              hypersensitivity to loudness.                                   receptor functions decline with pure aging, further interfering
           4. Common diseases in old age are superimposed upon                with balance. Clinical position sense does not decline with age.
              these changes, often resulting in worsening hearing
              impairment (e.g., cerumen impaction, otosclerosis,              IV. SENSATION
              8th N drug toxicity).                                                 A. Pain – Typically painful disorders are often less or not
                                                                              at all painful in elders.
           G. Taste buds don’t diminish, but salt detection declines;
      perception of sweet is unchanged, and bitter is exaggerated. The             1. Some cortical processing capacity for pain sensation ap-
      volume and quality of saliva diminish. All changes combine to                   pears to decline with age. When functional magnetic
      make eating less interesting. These aging changes are com-                      resonance imaging (fMRI) was used to compare cortical
      pounded by common diseases (periodontal) and medications.                       nociceptive responses to painful contact heat in healthy
                                                                                      young and older subjects, older subjects had significantly
           H. Smell acuity declines with aging. There is atrophy                      smaller pain-related fMRI responses in anterior insula
      of olfactory bulb neurons, and central processing is altered.                   (aINS), primary somatosensory cortex (S1), and supple-
      The result is decreased perception and less interest in food.                   mentary motor area. Gray matter volumes in S1 and aINS
      Again, these age-related changes are compounded by disease                      were significantly smaller in the elders, suggesting reduced
      (e.g., AD and PD have diminution and alteration of smell).                      processing capacity in these regions, perhaps accounting
                                                                                      for smaller pain-related fMRI responses.
      The Mini-Cog assessment instrument combines an uncued 3-item recall test with a clock-drawing test (CDT)
      that serves as a recall distractor. The Mini-Cog can be administered in about 3 min, requires no special equipment, and is
      relatively uninfluenced by level of education or language differences.

      ADMINISTRATION – The test is administered as follows:
            1. Make sure you have the patient’s attention. Instruct the patient to listen carefully to and remember 3 unrelated words
                 and then to repeat the words back to you (to be sure the patient heard them).
            2. Instruct the patient to draw the face of a clock, either on a blank sheet of paper, or on a sheet with the clock circle
                 already drawn on the page. After the patient puts the numbers on the clock face, ask him or her to draw the hands
                 of the clock to read a specific time (11:10 and 8:20 are most commonly used and more sensitive than some
                 others). These instructions can be repeated, but no additional instructions should be given. If the patient cannot
                 complete the CDT in =3 min, move on to the next step.
            3. Ask the patient to repeat the 3 previously presented words.

      SCORING – Give 1 point for each recalled word after the CDT distractor. Score 0–3 for recall.
         Give 2 points for a normal CDT, and 0 points for an abnormal CDT. The CDT is considered normal if all numbers are
             depicted, once each, in the correct sequence and position, and the hands readably display the requested time.
             Add the recall and CDT scores together to get the Mini-Cog Score:
         •   0–2 indicates positive screen for dementia.
         •   3–5 indicates negative screen for dementia.

       2. Endogenous pain inhibition is reduced with aging. Opioid-                        18. Resnick SM, Pham DL, et al. J Neurosci 2003;23:3295–301.
                                                                                           19. Rodríguez-Aranda C. Clin Neuropsychol 2003;17:203-15.
          mediated endogenous analgesic systems are particularly                           20. Shaffer SW, Harrison AL. Phys Ther 2007;87:193-207. Epub 2007 Jan 23. Review.
          susceptible to functional decline with aging. Additionally,                      21. Smith CD, Chebrolu H, et al. Neurobiol Aging 2007;28:1075-87. Epub
          older age is associated with reduced beta-endorphin levels.                          2006 Jun 13.
                                                                                           22. Smith DE, Rapp PR, et al. J Neurosci 2004;24:4373–41.
       3. Some pain thresholds show age-related changes. Al-                               23. Tumeh PC, Alavi A, et al.. Semin Nucl Med 2007;37:69-87. Review.
          though sensitivity to heat pain is decreased with age                            24. Ward NS. Ageing Res Rev 2006;5:239-54. Epub 2006 Aug 14. Review.
          (above), sensitivity to pressure pain is enhanced.
       4. Both Substance P and calcitonin gene-related pep-                                                                    ,      ,
                                                                                                 Richard W. Besdine, MD, FACP AGSF is Professor of Medicine,Greer
          tide (CGRP), major neuro-transmitters of primary af-                             Professor of Geriatric Medicine, Director, Division of Geriatrics (Medi-
          ferent nociceptive fibers, are decreased with aging,                             cine), and Director, Center for Gerontology and Healthcare Research, at
          likely reflecting reduction in density or function of                            The Warren Alpert Medical School of Brown University.
          nociceptive nerves. The rate of CGRP axonal trans-                                     Difu Wu is a student at The Warren Alpert Medical School
          port also decreases with advancing age.                                          of Brown University.

     B. Sensory nerves lose myelin selectively, perhaps pre-                               Disclosure of Financial Interest
disposing to neuropathy. Vibration sensation perception di-                                    Richard W. Besdine, MD, FACp, AGSF. Grant Research
minishes with aging, especially in the legs. Since position sense                          Support: Donald W. Reynolds Foundation
is carried in the same tracts as vibration, diminished vibratory                               Difu Wu has no financial interests to disclose.
sense should be followed up by position sense testing.
REFERENCES                                                                                 Richard W. Besdine, MD, FACP, AGSF
1.    Beers MH (Ed). The Merck Manual of Geriatrics. 3th Ed. NJ: Merck & Co., Inc, 2006.   Center for Gerontology and Healthcare Research
2.    Boeve B, McCormick J, et al. Neurol 2003;60:477-80.
3.    Borson S, Scanlan J, et al. Int J Geriatr Psychiatry 2000;15:1021-7                  The Warren Alpert Medical School of Brown University
4.     Burke SN, Barnes CA.. Nat Rev Neurosci 2006;7:30–40                                 2 Stimson Avenue
5.    Craft S, Cholerton B, Reger M. Aging and Cognition: What is Normal? In:              Box G-ST
      Hazzard WR, Blass JP, , et al, eds., Principles of Geriatric Medicine & Gerontol-
      ogy, 5th Ed. NY: McGraw-Hill, 2003:1370-1.                                           Providence, Rhode Island 02912
6.    Galban CJ, Maderwald S, et al. J Gerontol A Biol Sci Med Sci 2007;62:453-8.          e-mail:
7.    Gibson SJ, Farrell M. Clin J Pain 2004 ;20:227-39.
8.    Keuker JI, Luiten PG, Fuchs E. Neurobiol Aging 2003;24:157–65.
9.    Kirkwood TB. Cell 2005;120:437–47.                                                                    8SOW-RI-GERIATRICS-053008
10.   Lindeboom J, Weinstein H. Eur J Pharmacol. 2004;490:83-6.
11.   Mattay VS, Fera F, et al. Neurol 2002;58:630-5.
                                                                                             THE ANALYSES UPON WHICH THIS PUBLICATION IS BASED were
12.   Mrak RE, Griffin ST, Graham DI. J Neuropathol Exp Neurol 1997;56:1269–75.              performed under Contract Number 500-02-RI02, funded by
13.   Nanda A, Besdine RW. Dizziness. In. Halter JB et al, editors. Principles of            the Centers for Medicare & Medicaid Services, an agency of
      Geriatric Medicine and Gerontology. 6th Ed. New York. McGraw-Hill; 2003.               the U.S. Department of Health and Human Services. The con-
14.   Nusbaum AO, Tang CY, et al.. AJNR Am J Neuroradiol 2001;22:136-42.                     tent of this publication does not necessarily reflect the views
15.   Peters R. Postgrad Med J 2006;82:84–8.                                                 or policies of the Department of Health and Human Services,
16.   Quiton RL, Roys SR, et al. Ann N Y Acad Sci 2007;1097:175-8.                           nor does mention of trade names, commercial products, or
17.   Raz N. The ageing brain: structural changes and their implications for cogni-          organizations imply endorsement by the U.S. Government.
      tive ageing. In New Frontiers in Cognitive Ageing, Dixon R, Backman L, Nilsson         The author assumes full responsibility for the accuracy and
      L (eds). Oxford University Press: Oxford, 2004; 115–34.
                                                                                             completeness of the ideas presented.
                                                                                                                                 VOLUME 91          NO. 5      MAY 2008
                   Mild Cognitive Impairment, Healthy Aging and
                                Alzheimer’s Disease
                                                             Chuang-Kuo Wu, MD, PhD

      As predicted in 1976, the growth of              tation of dementia.7 In a five-year, pro-        and other neuropsychological batteries,
      the elderly population has resulted in a         spective, longitudinal study of healthy eld-     to be used as screening tests.
      tremendous increase in Alzheimer’s dis-          erly adults (above 75 years of age),                   Clinicians encounter several pitfalls
      ease (AD).1 In 2007, there were prob-            Verghese et al. reported that the elderly        when diagnosing MCI. It is caused by a
      ably more than 5 million Americans suf-          (n=345; age 78.9) who participated in            variety of pathologies other than just AD.
      fering from AD.2 The major advances in-          three kinds of cognitive activities and one      To predict that a MCI patient is in the pro-
      clude more clinical tools to diagnose AD         physical activity had a reduced risk of de-      dromal stage of AD, we have to consider
      and several medications approved by the          mentia. 8 Reading, playing board games           other differential diagnoses. In the elderly,
      FDA for treatment.                               and playing musical instruments are              the two most common conditions which
                                                       deemed beneficial cognitive activities;          can mimic MCI are depression and stroke.
           Our goals are:                              dancing is the only physical activity iden-      Patients with late-life depression commonly
           - Recognizing healthy, successful           tified that is associated with a lower risk of   complain of memory and cognitive prob-
             aging of cognition and devel-             dementia. They also observed that subjects       lems. By sophisticated neuropsychological
             oping strategies for primary              (n=124; age 79.7) who eventually devel-          testing, their cognitive functions are usu-
             prevention                                oped dementia (the majority of them had          ally within normal limits and subjective
           - Developing new disease modi-              AD) were older individuals with lower lev-       memory problem can be restored by ad-
             fying agents to alter the course          els of education (less than 12 grades) and       equate treatment. Older adults who had a
             of AD.                                    relatively lower test scores (on two memory      sudden onset of cognitive impairment of-
           - Defining mild cognitive im-               tests) at baseline. This landmark study pro-     ten had a cerebrovascular event. Recent
             pairment (MCI) as a diagnos-              vides evidence of risk-reducing activities       studies have reported that patients with the
             tic entity for early intervention.        to delay the onset of AD.                        amnesic-type of MCI often do have under-
                                                                                                        lying AD pathology. For example, Morris
                                                         Currently the FDA                              has proposed that since so many amnesic
      HEALTHY     AND   SUCCESSFUL       AGING                                                          MCI patients have AD pathology the di-
            Healthy aging is defined by the lack           approves no                                  agnostic criteria need to be revised.12 In con-
      of a significant decline in physical and
      mental abilities.3 These people are socially
                                                        treatment for MCI                               trast, the Mayo clinic reported that 71%
                                                                                                        of amnesic MCI brains displayed the AD
      active and emotionally satisfied. One defi-      because all the data                             pathology but that 29% of them showed
      nition of “successful aging” is that the eld-    indicate a clear lack                            non-AD pathologies, which particularly
      erly who perform in the upper end of a                                                            affected the mesial temporal regions.13
      distribution of test scores are deemed suc-           of benefit.                                       Neurochemical studies of MCI brains
      cessful.4 The effect of aging on cognition                                                        have demonstrated upregulation of the syn-
      is a hot topic. People older than 65 con-        MILD COGNITIVE IMPAIRMENT                        thetic cholinergic enzyme, suggesting no
      tinue to change through the rest of their        (MCI)                                            decline of acetylcholine in MCI brains. This
      lives in different ways. A wide variety of             The term, mild cognitive impair-           fits with the observation that all published
      age-related phenomena have been de-              ment (MCI), was initially used as stage 3        clinical trials to date of cholinesterase in-
      scribed.5 Many studies have documented           of Reisberg’s Global Deterioration Scale         hibitors show no significant efficacy.14 Cur-
      various life styles leading to healthy or suc-   (GDS) in the staging of AD.9 Petersen,           rently the FDA approves no treatment for
      cessful aging.3,4,5 Learning from these stud-    et al then proposed MCI as a diagnostic          MCI because all the data indicate a clear
      ies, preventive strategies are postulated to     entity for the transition between normal         lack of benefit.
      delay the onset of dementia. Among them,         aging and AD.10 In 2001, the American
      education and participation in certain lei-      Academy of Neurology published its               ALZHEIMER’S DISEASE
      sure activities are two areas which have         guideline for the diagnosis of MCI.11 The              In the near future, we will witness
      demonstrated benefit.6,7                         criteria include 1) memory complaint 2)          major advances in the treatment of AD,
            From epidemiological data, Katzman         objective memory impairment 3) normal            such as the introduction of disease-modify-
      pointed out that elder people with poor          general cognitive function 4) intact             ing agents. None are yet available, however.
      or no education have an increased risk of        ADLs 5) not demented by DSM IV cri-              The first crucial step in treating AD patients
      developing dementia6 compared to those           teria. The clinical tools recommended            is to classify the clinical stage. (Figure 1).
      better educated. It is postulated that edu-      according to the guideline are the Mini-         Today only symptomatic treatments are
      cation might generate brain “reserve”,           Mental State Examination (MMSE), the             available for AD, including cholinesterase
      which can compensate the initial presen-         Clinical Dementia Rating (CDR) scale             inhibitors (CEIs) and a NMDA receptor
                                                                                                          5. Baltes PB, Baltes MM. Psychological perspectives
                                                                                                              on successful aging. In: Baltes PB, Baltes MM.
                                                                                                              Editors. Successful aging. Cambridge University
                                                                                                              Press; 1990:1-34.
                                                                                                          6. Katzman R. Neurol 1993;43:13-20.
                                                                                                          7. Zhang M, Katzman R, Dalmon D Ann Neurol
                                                                                                          8. Verghese J, Lipton RB, et al. NEJM
                                                                                                          9. Flicker C, Ferris SH, Reisberg B. Neurol
                                                                                                          10. Petersen RG, Smith GE, et al. Arch Neurol 1999;
                                                                                                          11. Petersen RG, Stevens JC, et al. Neurol 2001;
                                                                                                          12. Morris JC. Arch Neurol 2006; 63:15-6.
                                                                                                          13. Jicha GA, Parisi JE, et al. Arch Neurol 2006;
                                                                                                          14. DeKosky ST, Ikonomovic MD, et al. Ann Neurol
                                              Figure 1.                                                       2002; 51:145-55.
                                                                                                          15. Jelio V, Kivipelto M, Winblad B. JNNP 2006;
antagonist. Since 1992,the FDA has ap-               with a significant decline in ADLs from the
proved five medications to treat Alzheimer’s         mild to moderate stage; likewise, a score be-
                                                                                                                Chuang-Kuo Wu, MD, PhD, is Associate
disease. We no longer prescribe tacrine be-          low 15 indicates a further decline toward
                                                                                                          Director, Clinical core of NIA-Funded ADC Cog-
cause of significant side effects. Donepezil,        the moderate to severe stage.
                                                                                                          nitive Neurology and Alzheimer’s Disease Center,
rivastigmine and galantamine are approved                  Treating the cognitive problems of AD
                                                                                                          and Assistant Professor, Department of Neurology,
for treating mild to moderate stage of AD.           patients is limited to those approved by the
                                                                                                          Northwestern University Feinberg School of Medi-
In 2004, memantine was approved for the              FDA. When AD patients receive treat-
                                                                                                          cine. Until July 31, 2007, Dr.Wu was an assistant
moderate to severe stage of AD. In 2007,             ment, we should monitor progress of dis-
                                                                                                          professor of clinical neurosciences, The Warren
donepezil won approval for the severe stage          ease with the MMSE. A 4-point decline
                                                                                                          Alpert Medical School of Brown University, and
of AD; rivastigmine has a skin patch ap-             within a short period (6 months) deserves
                                                                                                          associate director of the Alzheimer’s disease and
proved to treat the mild to moderate AD.             repeated clinical evaluation for other medi-
                                                                                                          memory disorders center of Rhode Island Hospital.
      In the clinic, patients can be evaluated       cal conditions which can worsen cognition.
simply by the MMSE as the first assessment           The combination of CEIs and memantine
                                                                                                          Disclosure of Financial Interests
tool. Many clinical scales have been devel-          is recommended for treating the moderate
                                                                                                                The author has no financial inter-
oped to replace the MMSE. However, the               to severe AD patient if side effects are toler-
                                                                                                          ests to disclose.
MMSE yields a significant amount of data             able. Memantine is not approved for mild
for interpretation. The first step in establish-     AD or MCI diagnosis.
ing the diagnosis of AD is to rule out other
                                                                                                          Chuang-Kuo Wu, MD, PhD
mimicking conditions, both treatable and             REFERENCES
                                                     1. Katzman R. Arch Neurol 1976; 33:217-8.
                                                                                                          Northwestern Memorial Hospital
untreatable. For example, a typical, high
                                                     2. Hebert LE, Scherr PA, et al. Arch Neurol          675 North St. Clair Street
school-educated, 70 year-old patient comes
                                                        2003;60:1119-22.                                  Galter 20-100
in with a caregiver complaining of a memory          3. Reichstadt J, Depp CA, et al. Am J Geriatr Psy-   Chicago, IL 60611
problem, and scores 24/30. Based on the                 chiatry 2007;15:194-201.
                                                     4. Fritsch T, McKee MJ, et al. t Gerontologist
                                                                                                          phone: 312-695-9627
education level and age, the score suggests a
                                                        2007;47:307-22.                                   e-mail:
high probability of dementia. Using a set of
laboratory tests and a brain scan (CT or
MRI), a clinician can confidently rule out
other causes and establish AD as the cause
of dementia (two-step approach). Scores of
12 to 23 are usually considered the mild to
moderate stage of AD, as defined in the cho-
linesterase inhibitor clinical trials. A score be-
low 15 indicates the moderate to severe
range. However, there is no consensus about
the defined score for the moderate stage of
AD. The Alzheimer’s Disease Cooperative
Study (ADCS) group reported that the abil-
ity to perform a wide range of instrumental
and basic ADLs correlates well with the
MMSE scores of AD patients. A significant
drop on the MMSE to below 20 correlates
                                                                                                                    VOLUME 91        NO. 5      MAY 2008
                                                             Gait In the Elderly
                                                                    Joseph H. Friedman, MD

      A number of impressive statistics on                        Gait disorders may occur for a num-        of the base, with scissoring, the crossing of
      falls in the elderly are routinely cited in            ber of reasons, and most are non-neuro-         feet, being an extreme example, most of-
      review articles.1,2 Interestingly, none of             logical in origin. Joint pain, muscle weak-     ten seen in people who were born with a
      them are recent. 1,2 My guess is that as the           ness, deformities, blindness, vestibular        form of cerebral palsy.
      population ages, these numbers will                    dysfunction, psychological factors, poorly
      worsen. In addition, abandonment of the                fitting shoes (especially in those with         4. Stride and foot strike
      “chemical straitjacket” routinely used for             edema and bunions) and deconditioning                 The stride length depends on the speed
      the demented twenty years ago which                    all may play a role. Pain, shoes, feet and      of gait as well as the height of the subject. Ex-
      rendered poor walkers into non-walkers                 blindness should be asked about.                cessively long strides are rare, and produce a
      may have increased fall frequency.                          Weakness and numbness may be pe-           “loping” quality, whereas short steps are com-
             For example, data from 1988, still              ripheral nervous system contributions to gait   mon, especially in the elderly, seen in parkin-
      cited in recent articles, 1,2 state that one third     disorders or may result from central ner-       sonian disorders as well as “fear of falling” in
      of people over age 65 fall each year, and              vous disorders. Increased tone, ataxia, weak-   which people walk as if they are on ice. In
      for half of them this is an ongoing prob-              ness and abnormal “motor programs” are          asymmetric disorders, such as Parkinson’s dis-
      lem.3,4 Ten percent of these falls results in          central nervous system abnormalities.           ease, one stride length may be shorter than
      significant morbidity (data from early                                                                 the other, producing a limping gait.
      1990s).5 Presumably these numbers in-                  COMPONENTS        OF GAIT                             In normal gait the heel strikes the
      crease with age. Falls are the fifth most com-         1. Ability to stand                             ground first, but in Parkinsonian disor-
      mon cause of death in the elderly. Only                     The patient should be asked to stand       ders there is a flat foot strike. In spastic
      25% of patients who suffer hip fractures               without using her arms. They may be kept        disorders the ball of the foot hits first.
      regain their former level of function. And             folded across the chest or put into a pray-     These different foot strike patterns may
      falls frequently induce a fear of falling,             ing position. If the patient cannot do this,    be reflected in wear on the shoes.
      which itself contributes to the problem.               she should try to stand pushing off from
             Impairment in mobility affects 14%              the armrests on her chair. A note should        5. Armswing
      of those between 65 and 74 but half of those           be made of how easily the patient was able            This is not important in the biophysics
      over 85.6 This impairment occurs for a                 to do this or whether the doctor needed         of walking but is extremely important in mak-
      number of reasons, including brain                     to help.                                        ing diagnoses. The armswing is reduced in
      changes, both normal and pathological, as                                                              Parkinsonism, for example, generally more
      well as changes in muscles and the sensory             2. Posture                                      reduced on the worse side, possibly absent on
      organs (eyes, vestibular apparatus, periph-                 Patients with an abnormal posture will     one side and normal on the other. Armswing
      eral nerves). Normal aging produces physi-             generally have kyphosis, scoliosis or some      is absent after a stroke. In patients with ataxic
      cal changes that overlap with the signs of             degree of both. Rare patients will have a       syndromes the arms are often abducted, as if
      Parkinson’s disease, except for tremor.7               hyperlordotic posture from lower spinal         supplying extra balance. T   remor may be seen
             The clinical importance of gait can-            muscle weakness or dystonia. Kyphosis is        only during walking in Parkinson’s disease,
      not be overestimated. In a nursing home                usually idiopathic, but may be due to com-      whereas tremor is not seen during walking in
      evaluation, every single patient seen by               pression fractures, Parkinson’s disease,        patients with essential tremor. In choreiform
      this author had a significant gait abnor-              spondylitis. The curvature may occur any-       disorders, such as generalized tardive dyski-
      mality. Of course, in many cases, that was             where from the lumbar spine up. In PD,          nesia or Huntington’s disease, the armswing is
      why they were not living at home.                      for example, patients may have highly vari-     often excessive. It may also be excessive in some
             It is my hypothesis that gait abnormali-        able degrees of flexion in the thorax or the    disorders in which there is a short stride, as if
      ties are often not identified by doctors because       neck or both.                                   to compensate.
      it has not been part of their training. In the
      outpatient setting, doctors, for efficiency, tend      3. Base                                         6. Turning
      to see patients in examining rooms, partially               The normal width of foot placement               A normal turn requires a pivot. One
      undressed, seated on the examining table. In           is considered the width of the shoulders.       foot is kept on the ground and rotation
      the hospital, it is difficult to get patients out of   The base should be noted both when              occurs on the ball of that foot. In Parkin-
      bed or off their stretchers, and a lot more dif-       standing and when walking. Ataxic gaits,        sonism the patient turns “en bloc,” in one
      ficult to get them back on them, especially in         due to sensory problems, cerebellar or ves-     piece, using two or more steps. Some-
      the emergency department where the stretch-            tibular dysfunction will cause the base to      times the patient turns in a large circle,
      ers are quite high.                                    increase or to vary. Spastic problems, due      as if making a U-turn. Turning fre-
             The basic problem is the lack of a              to corticospinal tract dysfunction, as seen     quently causes loss of balance, in all gait
      language for describing and classifying                in spastic forms of cerebral palsy, stroke or   disorders.
      gait problems.                                         cervical myelopathies, cause a narrowing
7. Pull test                                   Armswing is normal, but sometimes re-                   4. Nevitt MC, Cummings SR, et al. Risk factors for
                                                                                                          recurrent nonsyncopal falls. JAMA
     This test, like the Romberg, tests bal-   duced when the arms are abducted, act-
ance. The pull test is performed by in-        ing like a balancing rod used for tight-                5. Nevitt MC, Cummings SR, Hudes ES. Risk factors
forming the patient that you are going         rope walkers. Alcohol intoxication pro-                    for injurious fall. J Gerontol 1991;46:M164-M170.
to pull him off balance and that he            duces an ataxic gait.                                   6. Odenheimer G, Funkenstein H, et al. Compari-
                                                                                                          son of neurologic changes in “successful aging”
should try to keep from falling, taking as           5. Post stroke: armswing is lost on the
                                                                                                          persons vs the total aging population. Arch Neurol
few steps as possible. It is important to      affected side, and the arm is often flexed                 1994;41:573-80.
pull hard enough to make the patient           at the elbow, and wrist, while adducted at              7. Critchley M. Neurolocial changes in the aged. Res
take a step or two. Taking more than three     the shoulder. The affected leg is typically                Publ Assoc Res Nerv Mental Dis 1956;35:198-223.
steps is considered abnormal, indicative       kept in extension, as if acting like a crutch.
of a balance problem.                          The leg is moved in a circular fashion as
                                               the knee is not bent. The ball of the foot       
INTERPRETATIONS                                usually hits the ground first.                             neurologicexam/html/
      As in most aspects of the neurologi-           6. Spastic: this is seen in children or              gait_abnormal.html contains infor-
cal examination, the cardinal feature is       adults with cereral palsy, but also with                   mation on gait including video ex-
symmetry. When the stride length is dif-       other bilateral corticospinal dysfunction,                 amples of a doctor simulating and
ferent on the two sides, we usually see a      typically after bilateral strokes, multiple                explaining common gait disorders as
limp or scuffing of one foot. Asymmetric       sclerosis or cervical myelopathy, as occurs                well as including examples. Other
armswing is obvious, once you look for         with cervical spondylosis. The posture is                  websites cited include information
it. When the gait looks abnormal, try to       normal. The legs are stif and do not bend                  about gait, both for health profes-
break it down into the component parts         normally at the knees. The base narrows.                   sional and patient.
listed above to see if the abnormality can     Because the legs are kept extended, the
be localized. When the patient shifts          ball of the foot usually hits the ground
weight suddenly, it is often an indication     first. Stride length is reduced. Armswing                     Joseph H. Friedman, MD, is execu-
of joint pain, and this should be inquired     changes are determined by the level of                  tive editor of Medicine & Health/Rhode
about.                                         the lesions so that in brain diseases, the              Island.
                                               armswing is reduced. When the spastic
Examples:                                      gait arises from a cervical process, it may             Disclosure of Financial Interests
      1. Foot drop: the affected foot is       or may not be reduced.                                      Joseph Friedman, MD, Consultant:
lifted higher than normal and then the               7. Cautious gait. This is the gait of             Acarta Pharmacy, Ovation, Transoral;
ball of the foot is dropped onto the           someone fearful of falling, which, para-                Grant Research Support: Cephalon, Teva,
ground or is thrown forward and                doxically, may increase the risk. The pa-               Novartis, Boehringer-Ingelheim, Sepracor,
slapped.                                       tient walks as if on ice, with slow, deliber-           Glaxo; Speakers’ Bureau: Astra Zeneca,
      2. Hip weakness produces a wad-          ate steps, placing each foot flatly and sol-            Teva,Novartis, Boehringer-Ingelheim,
dling gait. To lift the swing leg and move     idly on the ground before advancing.                    GlaxoAcadia, Sepracor, Glaxo Smith Kline
it forward, weight is shifted to the sup-            8. Astasia abasia. This is an old term,
porting leg by tilting the pelvis up on the    meaning “can’t sit, can’t stand,” used for              CORRESPONDENCE
swing side. This is usually a symmetric        conversion disorder, or psychogenic gait                Joseph H. Friedman, MD
problem so that the hip swivels up and         disorders. Although these are considered                Neurohealth
down.                                          rare in the elderly, they do occur. Gener-              227 Centreville Rd.
      3. Parkinsonism is one of the most       ally the gait is extremely bizarre, and,                Warwick, RI 02886
common gait in the elderly, and not al-        unlike other gait disorders where the                   e-mail:
ways pathological.7 The posture is stooped,    body tries to minimize risk and effort,
the stride length is reduced and there is a    these generally maximize effort and pro-
tendency for a flat foot strike. Armswing      duce convoluted postures, standing on                               Professional or
is reduced. Turning is without a pivot and     one leg and other unusual stresses to the                           Medical Office
balance is impaired on the pull test. As the   balance systems. Contrary to popular                                Space to Lease
gait deteriorates, the patient will often be   belief, these disorders are not generally
                                                                                                                  Two office suites on bottom
flexed at the knees, which causes a major      associated with “belle indifference” or                             Floor of medical building.
increase in weightbearing problem for the      with the absence of falls or injuries.                                 One @ 600 SF & one
thigh muscles.                                                                                                    @ 900 SF. Can be combined
                                                                                                                  into a single unit. Park Ave.,
      4. Ataxic: this may be from cerebel-     REFERENCES                                                          Cranston, minutes from RT
lar dysfunction, vestibular impairment or      1. Moylan CK, Binder EF. Fall in older adults. Am J                95 & RT 10. Ample Parking.
                                                  Med 2007;120:493-7.                                               Perfect for a specialist or
sensory denervation. The stance may be
                                               2. Tinetti ME. Preventing falls in elderly persons.                 allied health professional-
normal or wide, but the gait is irregular         NEJM 2003;348:42-9.                                               internist on the 2nd floor.
and often lurching, with a tendency to         3. Tinetti ME, Speechley M, Ginter SF. Risk factors
                                                  for falls among elderly persons living in the com-                   Contact Sharli at
veer to one side, or to either side, with                                                                               401-275-0700
                                                  munity. NEJM 1988;319:1701-7.
increased problems on turning.
                                                                                                                 VOLUME 91         NO. 5      MAY 2008
                                   Parkinson’s Disease In the Elderly
                                                     Marie-Hélène Saint-Hilaire, MD, FRCPC

           An 82 year old woman was ad-               gidity. Asymmetry of physical findings is         ability.5 They are however under recog-
           mitted to a rehabilitation hospi-          important to support the diagnosis, as is         nized because their symptoms can over-
           tal after sustaining a pelvic frac-        a good response to levodopa.                      lap with the symptoms of PD.
           ture. She had a past history of os-              Several clinical features help to dis-            Non-motor symptoms affect several do-
           teoporosis and chronic lower back          tinguish idiopathic PD from other causes          mains: neuropsychiatric, autonomic, sensory,
           pain treated with epidural ste-            of parkinsonism. The presence of early            sleep, and dermatologic. Dementia, depres-
           roids. For the past two years she          falls, a poor response to levodopa, sym-          sion and autonomic symptoms are often the
           had had several falls associated           metry of signs at onset, or significant au-       most problematic in elderly PD patients.
           with fractures. She also reported          tonomic dysfunction should raise the sus-
           drooling, difficulties swallowing,         picion that the patient may not have id-          DEMENTIA
           gait shuffling and freezing, and           iopathic PD.                                            The prevalence of dementia in PD var-
           tremor in the left hand, more at                 In addition, significant cognitive de-      ies between 10 and 44% depending on the
           rest than with action. She had no          cline and hallucinations, within one year         diagnostic criteria used and the nature of the
           cognitive impairment. She was              of onset of the parkinsonian signs is sug-        population studied. The risk increases with
           started on a small dose of levodopa/       gestive of a diagnosis of dementia with           age, with one study finding that 65% of PD
           carbidopa 25/100, a half three             Lewy Bodies. Concomitant PD and                   patients over the age of 85 were demented.6
           times a day. She responded very            Alzheimer Disease (AD) are also possible          Risk factors include older age at onset, and
           well, stopped drooling, and had            in this age group. The diagnosis can be dif-      initial manifestations of hypokinesia and ri-
           improvement in swallowing, gait,           ficult, because some patients with AD have        gidity.7 The dementia in PD usually does not
           and tremor. However, her balance           parkinsonian features. The presence of an         appear at the onset of the disease. It is char-
           remained impaired and she con-             asymmetric rest tremor, and improvement           acterized by impaired executive function,
           tinued to need a walker.                   of the motor signs with levodopa lend sup-        visuospatial abnormalities, impaired
                                                      port to a diagnosis of PD.                        memory, and language deficits.8 In elderly
           This case exemplifies some of the chal-          It is always necessary to review all the    patients, superimposed cerebrovascular dis-
      lenges in diagnosing and treating elderly       medications taken by the patient, because         ease can contribute to cognitive problems.
      patients with Parkinson’s Disease (PD):         many have extrapyramidal side effects. Po-        Dementia is a major factor in the manage-
      1) concurrent medical conditions, such as       tential culprits include atypical neuroleptics,   ment of PD, limiting the drug therapy that
      arthritis, can affect mobility, and symptoms    (i.e. risperidone), antiemetics (i.e.             can be used, and leading to earlier nursing
      can overlap with the symptoms of PD, thus       metoclopramide), some antidepressants (i.e.       home placement and decreased survival.2
      delaying the diagnosis; 2) although treat-      fluoxetine) and some antiepileptics (i.e.
      ment with levodopa is beneficial, it does       valproic acid). Other conditions to exclude,      DEPRESSION
      not eliminate gait and balance problems,        especially in the elderly, are cerebrovascular         Around 40% of subjects will have
      which are major causes of morbidity.            disease and normal pressure hydrocephalus         depression. 9 Although there may be a psy-
           Age remains the single most impor-         which usually present as a gait disorder or       chological response to living with a pro-
      tant risk factor in PD. Although the av-        “lower body parkinsonism.”                        gressive neurological disease, there is evi-
      erage age of onset of PD is around 60,                Patients with late onset PD progress at     dence that depression in PD is related to
      the incidence rates consistently increase       a greater rate and are more cognitively im-       the underlying pathology of the disease.
      through age 85.1 Aging does appear to           paired than those with early onset disease.            There is overlap between the symptoms
      directly influence the clinical expression      They also have more bradykinesia and pos-         of depression and those of PD which can
      of PD, and late onset PD patients offer         tural instability3. Lack of tremor, male sex,     make the diagnosis challenging. The nature
      special challenges because of polyphar-         and associated comorbidities are also associ-     of the depression in PD is more character-
      macy, multiple pathology, and coexisting        ated with a more rapid rate of progression2.      ized by pessimism, hopelessness and poor
      cognitive problems. This article will re-                                                         motivation, with less feeling of guilt and self
      view the specific aspects of the clinical       NON-MOTOR SYMPTOMS                                blame than in depressed elderly subjects with-
      presentation, differential diagnosis and              Non-motor symptoms are increas-             out PD. Psychotic features are rare.10
      treatment of PD and its complications in        ingly recognized as an intrinsic feature of
      the elderly population.                         PD. Their prevalence is high: A survey            AUTONOMIC DYSFUNCTION
                                                      found that 88% of PD patients had at least              Symptoms of autonomic dysfunction
      CLINICAL PRESENTATION                           one non-motor symptom, and 11% had                become more prominent as PD progresses.
           The diagnosis of PD is based on the        five.4 With improvement in the treatment          They also increase with age and medica-
      history and the clinical examination. It        of PD motor symptoms, non-motor symp-             tion use.11 They include bladder dysfunc-
      requires the presence of two of the fol-        toms, such as dementia and depression,            tion, constipation, orthostatic hypotension,
      lowing: rest tremor, bradykinesia or ri-        have become an important cause of dis-            abnormal sweating and sexual dysfunction.
In addition, age itself affects autonomic                   The treatment of the non-motor symp-       REFERENCES
function, as do concurrent diseases such as           toms of PD must be addressed specifically        1. Mayeux R, Marder K, et al. The frequency of
                                                                                                           idiopathic Parkinson’s disease by age, ethnic group,
diabetes and hypertension, and medica-                and separately from the treatment of the
                                                                                                           and sex in northern Manhattan, 1988-1993. Am
tions, including some used to treat PD.               motor symptoms. The only medication ap-              J Epidemiol 1995; 142:820-7.
                                                      proved for the treatment of PD dementia          2. Suchowersky O, Reich S, et al. Practice Parameter.
Orthostatic hypotension                               is Rivastigmine.14 There is no medication            Report of the Quality Standards Subcommittee
                                                                                                           of the American Academy of Neurology. Neurol
     Falls in blood pressure (BP) occur               specifically approved for the treatment of           2006; 66: 968-75.
particularly when getting up in the morn-             depression, bladder or sexual dysfunction,       3. Diederich NJ, Moore CG, et al. Parkinson disease
ing, or after meals. They manifest as dizzi-          constipation, or orthostatic hypotension in          with old-age onset. Arch Neurol 2003; 60:529-33.
ness when the patient stands, but can also            PD. For any treatment being considered,          4. Shulman LM, Taback RL, et al. Comorbidity of
                                                                                                           the nonmotor symptoms of Parkinson’s disease.
present as fatigue or episodes of confusion.          the clinician must weigh the potential ben-          Mov Disord 2001; 16: 507-10.
Critical review of all prescribed medica-             efit versus the risk of side effects.            5. Weintraub D, Moberg PJ, et al. Effect of psychiatric
tions is necessary but sometimes specific                                                                  and other nonmotor symptoms on disability in
treatment such as fludrocortisone or                                                                       Parkinson’s disease. J Am Geriatr Soc 2004; 52:784-8.
proamatine must be instituted.
                                                        Patients with late                             6. Mayeux R, Chen J, et al. An estimate of the inci-
                                                                                                           dence of dementia in idiopathic Parkinson’s dis-
                                                        onset PD progress                                  ease. Neurol 1990; 40:1513-6.
Bladder symptoms                                                                                       7. Miyasaki JM, Shannon K, et al. Practice
      Symptoms of urgency, frequency, noc-
                                                         at a greater rate                                 Parameter.Report of the Quality Standards Sub-
turia, and incontinence are common in ad-                 and are more                                     committee of the American Academy of Neurol-
                                                                                                           ogy. Neurol 2006; 66: 996-1002.
vanced PD. They result from detrusor hyper-
reflexia with or without detrusor/sphincter
                                                       cognitively impaired                            8. Aarsland D, Andersen K, et al. Prevalence and
                                                                                                           characteristics of dementia in Parkinson disease.
dyssynergia. In addition, they can be compli-            than those with                                   Arch Neurol 2003; 60:387-92.
                                                                                                       9. Cummings JL. Depression and Parkinson’s dis-
cated by prostatic hypertrophy in males. Un-
fortunately medications for detrusor hyper-
                                                       early onset disease.                                ease. Am J Psychiatry 1992; 149, 4: 443-54.
                                                                                                       10. Brown RG, MacCarthy B. Psychiatric morbidity
reflexia are anticholinergic and can exacer-                                                               in patients with Parkinson’s disease. Psycholog Med
bate confusion in elderly PD patients. Their          CONCLUSION                                           1990; 20: 77-87.
                                                                                                       11. Verbaan D, Marinus J, et al. Patient-reported au-
risks and benefits must be carefully weighed.               Elderly PD patients have more gait             tonomic symptoms in Parkinson disease. Neurol
                                                      and balance difficulties, more depression,           2007; 69: 333-41.
Constipation                                          cognitive problems, and autonomic dys-           12. de Goede CJ, Keus SH, et al. The effects of physi-
                                                                                                           cal therapy in Parkinson’s disease. Arch Phys Med
     Constipation is very common in PD,               function, in addition to concurrent diseases         Rehabil 2001; 82: 509-15.
because of a combination of autonomic                 such as cardiac and cerebrovascular disease.     13. Ramig LO, Sapir S, et al. Changes in vocal loud-
dysfunction with delayed transit time,                Drug therapy can be limited by neuropsy-             ness following intensive voice treatment (LSVT)
and immobility, drug therapy, poor diet               chiatric side effects, and has marginal ben-         in individuals with Parkinson’s disease. Mov Disord
                                                                                                           2001; 16: 79-83.
and lack of appropriate hydration. An ag-             efit for gait, balance, and swallowing diffi-    14. Emre M, Aarsland D, , et al. Rivastigmine for
gressive bowel regimen may be necessary               culties. In this situation a non-medical ap-         dementia associated with Parkinson’s Disease.
to avoid impaction.                                   proach involving physical and speech thera-          NEJM 2004, 351: 2509-18.
                                                      pies becomes an important part of the man-
TREATMENT                                             agement. A dietitian can also be involved             Marie-Hélène Saint-Hilaire, MD,
      Treatment must be individualized to             to recommend strategies to maintain              FRCPC, is Medical Director of the
each patient’s needs, and the functional and          weight, and an occupational therapist can        Parkinson’s Disease and Movement Disor-
cognitive status. Symptomatic therapy is in-          evaluate the home environment to improve         ders Center, Boston University School of
troduced when the patient is functionally             safety. As the disease progresses, it may be-    Medicine.
disabled. Levodopa/carbidopa is still the most        come increasingly difficult for patients to
effective medication for the motor symptoms           go to a specialty clinic. The primary care       Disclosure of Financial Interests
of PD, and is better tolerated than Dopam-            provider then becomes more involved in               Grant Research Support: Eisai,
ine Agonists, amantadine or anticholinergics          the management of the patient but must           Bayer, Novartis; Speaker’s Bureau: Teva,
in elderly patients. It is initiated at a low dose,   have access to consultation with the patient’s   Boeringher Ingelheim, Valeant
and increased slowly to minimize side effects.        specialist if necessary. The care of patients
The optimal dose is the lowest one that will          with advanced PD is complicated by the           CORRESPONDENCE
maintain adequate function. As the symp-              fact that the caregiver, usually a spouse, is    Marie-Hélène Saint-Hilaire, MD, FRCPC
toms of PD progress, the dosage of the medi-          also likely to be elderly and to suffer from a   Boston University School of Medicine
cation will need to be adjusted. However              chronic illness.                                 Department of Neurology
certain symptoms such as gait freezing, falls,                                                         715 Albany Street, C-329
hypophonia, and dysphagia do not respond                                                               Boston, MA 02118
well to drug treatment, and in these cases                                                             Phone: (617) 638-8640
physical therapy and speech therapy may be                                                             e-mail:
helpful.12, 13

                                                                                                                  VOLUME 91           NO. 5      MAY 2008
                                                Epilepsy In the Elderly
                                        Amanda M. Diamond, MD, and Andrew S. Blum, MD, PhD

            People over age 65 are the most rap-     global amnesia and dementia. Multiple            level relationships.8 Decreased protein
      idly increasing segment of the population.     metabolic etiologies can also be consid-         binding is more common in the aged; this
      The incidence of epilepsy rises signifi-       ered, including hypo- or hyperglycemia,          may lead to higher AED free fractions,
      cantly with age, starting with 25.8/           thyroid dysfunction, hypercapnia, ure-           which can lead to earlier toxicity with more
      100,000 person-years for the ages of 60-       mia and hyponatremia.7                           highly protein bound AEDs such as pheny-
      74 and increasing to 101.1/100,000 for              Electroencephalography can be               toin and valproate. Also, the elderly may
      the ages of 75-89.1 The prevalence of          pivotal, but one must be aware of po-            have a lower volume of distribution. De-
      epilepsy is 1.5% in the elderly, twice that    tential false positive findings. Rhythmic        creased clearance due to hepatic or renal
      of young adults.2 Also, the prevalence of      runs of temporal theta activity may be           insufficiency may also promote higher than
      epilepsy in nursing home residents is even     seen in drowsiness as a normal or benign         expected serum AED levels.9 The CNS
      higher than that in the general popula-        finding. Focal slowing may be present            threshold for AED toxicity may also be
      tion. Review of elderly nursing home           with underlying cerebrovascular insults.         lower in the elderly. Delayed esophageal
      residents reveals that up to 10.5% are         Wicket spikes and subclinical rhythmic           and gastric emptying, altered postprandial
      receiving anticonvulsants, along with an       electrographic discharges in adults              gastric pH, and delayed intestinal transit
      average of 5.6 other medications.3,4           (SREDA) are two other benign variant             all affect absorption in the elderly.10
                                                     patterns that can be misinterpreted.                   Several medications more common in
      ETIOLOGY    AND   SEMIOLOGY                    Long-term video-EEG monitoring                   the elderly can pose significant interactions
            In the elderly, cerebrovascular dis-     (LTM) may prove invaluable in evalu-             with some AEDs. For example, highly
      ease accounts for 30-40% of cases.2 The        ating recurrent spells. Brain imaging            protein bound AEDs (e.g. phenytoin and
      risk of seizures within the first year after   should be performed, preferably MRI.             valproate) may interact with warfarin and
      stroke has been estimated to be 23 times       Other testing considerations include ba-         other highly protein bound concomitant
      that of the general population.5 Other         sic metabolic screens, sleep studies,            medications, leading to complex untoward
      causes include Alzheimer’s disease,            Holter monitoring, echocardiogram,               interactions. Cytochrome P450-inducing
      trauma, brain tumors and infection.            tilt-table and/or vestibular testing,            AEDs (phenytoin, carbamazepine, phe-
      About half of cases are cryptogenic, and       where appropriate, to rule out compet-           nobarbital) accelerate the clearance of
      it is presumed that vascular etiologies ac-    ing diagnoses.                                   some hepatically cleared drugs, including
      count for much of this group too.2                                                              some chemotherapeutics.9
            Further complicating the diagnosis
      is the sometimes vague history. The
                                                     Several medications                                    Several AEDs are known to contrib-
                                                                                                      ute to accelerated bone demineralization.
      events are often unwitnessed and may             more common in                                 The older generation of AEDs seems to
      involve confusional symptoms. Elderly
      patients do not always have classical sei-
                                                     the elderly can pose                             be worse in this regard. The elderly are at
                                                                                                      a higher risk of osteoporosis and related
      zure semiologies or auras as in younger              significant                                fractures, so this may be relevant. Balance
      patients. Symptoms that may suggest al-
      ternate diagnoses can further confound;
                                                       interactions with                              and cognitive concerns are also enriched
                                                                                                      in the elderly. Some AEDs appear to pose
      these may include tremor, headache and              some AEDs.                                  greater balance risks (e.g. phenytoin,
      dizziness, among others.6 In a recent                                                           carbamazepine)11 or cognitive risks (e.g.
      VA study, 27% of patients ultimately di-       MANAGEMENT                                       phenobarbital, topiramate). Hyponatre-
      agnosed with epilepsy were initially mis-           The assistance of family members and        mia, a problem occasionally provoked by
      diagnosed as having syncope, altered           caregivers may be needed to ensure pa-           carbamazepine and oxcarbazepine, is
      mental status and confusion.6 Postictal        tient safety. In some, help with medica-         more frequent in the aged, particularly
      periods tend to be more prolonged in this      tions may be critical and the importance         with concomitant diuretic use.
      age group, at times lasting for several        of compliance should be emphasized.                    The elderly are likely to have more
      days.7                                         Patients may need a home safety evalua-          medical diagnoses and take more medica-
                                                     tion. Medication lists should be reviewed        tions than a younger population and thus
      DIFFERENTIAL DIAGNOSIS          AND            for potentially pro-convulsive medications.      are far more susceptible to drug-drug in-
      WORK-UP                                             Medical management of epilepsy in           teractions.3 AEDs that act as hepatic en-
           The differential diagnosis in this        the elderly poses several distinct challenges.   zyme inducers or inhibitors will greatly
      population is extensive and includes tran-     Pharmacokinetic and pharmacodynamic              augment this problem of drug-drug in-
      sient cerebrovascular symptoms (TIA),          parameters change significantly with age,        teraction burden in this age group. This
      syncope (including convulsive syncope),        making the potential for side effects of anti-   is more often the case for the older AEDs.
      confusional migraine, drug intoxication,       epileptic drugs (AEDs) greater and de-           The newer (2nd generation) AEDs exhibit
      infection, psychiatric disorders, transient    creasing the predictability of dose – blood      less hepatic affects and are more often
renally cleared, have lower protein bind-       zures in the elderly. After careful diagnosis,              14. Saetre E, Perucca E, et al. An international
                                                                                                                multicenter randomized double-blind controlled
ing, and hence have fewer drug interac-         AED choices should take into account me-
                                                                                                                trial of lamotrigine and sustained-release
tions as a group. Additionally, the elderly     tabolism, drug-drug in interactions, co-mor-                    carbamazepine in the treatment of newly diag-
may have more difficulty paying for AEDs,       bidities, and side effect profiles while striv-                 nosed epilepsy in the elderly. Epilepsia
contributing to potentially poor compli-        ing to achieve seizure freedom.                                 2007;48:1292-302.
                                                                                                            15. Leppik IE. Epilepsy in the elderly. Epilepsia
ance or restricted choice of agent.
                                                                                                                2006;47(Suppl 1):65-70.
ANTIEPILEPTIC     CHOICES IN THE                1. Hussain SA, Haut SR, Incidence of epilepsy
                                                                                                                  Amanda M. Diamond, MD, is a Fel-
                                                    in a racially diverse, community-dwelling, elderly
ELDERLY                                                                                                     low in Clinical Neurophysiology, Rhode
                                                    cohort. Epilepsy Res 2006;71:195-205.
      Little comparative efficacy data exist    2. Hauser WA. Epidemiology of Seizures in the eld-          Island Hospital and The Warren Alpert
to help guide the use of AEDs in the eld-           erly. In: Seizures and Epilepsy in the Elderly. Rowan   Medical School of Brown University.
erly. Most clinical trials of AEDs have been        AK, Ramsay RE, Eds. Boston, Butterworth-
                                                    Heinemann, 1997:7-18.                                         Andrew S. Blum, MD, PhD, is Direc-
conducted in younger and healthier adult        3. Lackner TE, Cloyd JC, et al. Antiepileptic drug          tor, Comprehensive Epilepsy Program, Rhode
populations. In the UK, Brodie et al12 com-         use in nursing home residents, Epilepsia                Island Hospital, and Assistant Professor of
pared the efficacy and tolerability of              1998;39:1083-7.
                                                                                                            Clinical Neurosciences, The Warren Alpert
lamotrigine vs. carbamazepine in elderly        4. Garrard J, Cloyd JC, Factors associated with
                                                    antiepileptic drug use among nursing home eld-          Medical School of Brown University.
patients with new onset epilepsy. They              erly. J Gerontol Med Sci 2000 ;55:384-92.
found similar efficacy but better tolerabil-    5. So EL, Annegers JF, Population-based study        Disclosure of Financial Interests
ity in the lamotrigine arm.12 A similar US          of seizures disorders after cerebral infarction.
                                                                                                                 Amanda M. Diamond, MD. Con-
study compared gabapentin vs. lamotrigine           Neurol 1996;46:350-355.
                                                6. Ramsay RE, Rowan AJ, Pryor FM. Special con-              sultant: Guidant, TEVA, Berlex (Bayer),
vs. carbamazepine in the elderly and found          siderations in treating the elderly patient with epi-   Genentech.
better tolerability in the gabapentin and           lepsy. Neurol 2004;62(Suppl 2):S24-S29.                      Andrew S. Blum, MD. Grant Re-
lamotrigine arms vs. carbamazepine with         7. Ramsay RE, Macias FM, Rowan AJ. Diagnosing
                                                                                                            search Support: Abbott Laboratories.
no significant efficacy distinctions.13 How-        epilepsy in the elderly. In “The Neurobiology of
                                                    Epilepsy and Aging” (RE Ramsay, ed.) Int Rev            Speaker’s Bureau: Glaxo SmithKline,
ever, a later international study that com-         Neurobiol 2007;81:1-14.                                 ICB Pharmos, Ortho-McNeil.
pared lamotrigine and carbamazepine us-         8. Perucca E, Berlowitz D, Pharmacological and            Discussion of off-label usage of any
ing a more flexible dosing schedule and slow        clinical aspects of antiepileptic drug use in the
                                                    elderly. Epilepsy Res 2006;68S:S49-S63.
                                                                                                            product: gabapentin and lamotrigine.
release carbamazepine did not observe as                                                                    Reference is made to studies performed
                                                9. Boggs JG. Elderly patients with systemic disease.
marked a tolerability difference.14                 Epilepsia 2001;42:18-23.                                on the use of these medications in eld-
      It is helpful when treating the eld-      10. Gidal BE. Drug absorption in the elderly. Epi-
                                                                                                            erly patients with epilepsy.
erly with epilepsy to keep the regimen as           lepsy Res 2006;68S:S65-S69.
                                                11. Fife TD, Blum D, Fisher RS. Measuring the ef-
simple as possible. Medication choices              fects of antiepileptic medications on balance in        CORRESPONDENCE
should be tailored to seizure type, with            older people. Epilepsy Res 2006;70:103-9.               Andrew S. Blum, MD, PhD
most being partial onset rather than gen-       12. Brodie MJ, StephenLJ. Outcomes inelderly pa-
                                                                                                            110 Lockwood St., Ste. 342
eralized in this population. Tolerability           tients with newly diagnosed and treated epilepsy.
                                                    Int Rev Neurobiolo 2007;81:253-63.                      Providence, RI 02903
concerns should be considered carefully         13. Rowan AJ, Ramsey MD, et al. New onset geriat-           Phone: (401) 444-4364
in AED selection and individualized ac-             ric epilepsy, Neurol 2005;64:1868-73.                   E-mail:
cordingly. Doses should generally begin
quite low and titration should be as slow
as possible .15 Levels may be helpful. Cost
may be a deciding factor for some.
      Fortunately, the majority of elderly
cases are very responsive to treatment.
Refractory epilepsy may be infrequently
encountered in this group. Non-phar-
macologic treatment options may be lim-
ited. Surgical resection is not as com-
monly used in this age group. Vagal nerve
stimulation may prove an option for some
when AEDs prove inadequate and sur-
gery is not a viable option.

      The incidence of epilepsy is higher in
the elderly than in younger adults. This com-
munity presents a challenging set of consid-
erations in diagnosis and management.
Numerous other processes may mimic sei-
                                                                                                                     VOLUME 91         NO. 5     MAY 2008
          Peripheral Neurology: Special Concerns In the Elderly
                                                               George M. Sachs, MD, PhD

      Changes in the peripheral nervous system           role of estrogen is less well established,      nervate muscle fibers with slow contrac-
      produce a major impact on safety and               though its sharp perimenopausal fall may        tion times. Type 2 motor units contain
      quality of life in the elderly. The chal-          help explain the relatively early onset of      larger motor neurons and muscle fibers
      lenges of aging reflect alteration of both         muscle loss in women.1,2                        that contract more quickly. Aging muscles
      neuromuscular and sensory function. Of                  The interaction of nerve and muscle        may show a shift toward the slower con-
      particular concern are motor and prop-             can be described in terms of “ motor units”.    tractions of Type 1 units for a few rea-
      rioceptive deficits increasing the risk of         One motor unit consists of a single spinal      sons. First, aging leads to selective Type 2
      falls. In addition, changes in sensory path-       motor neuron and the muscle fibers it sup-      fiber atrophy. Whether this simply re-
      ways may predispose the elderly to neu-            plies through the branches of its axon. A       flects decreased physical activity or some
      ropathic pain. This review will focus on           motor unit in hand muscles typically in-        other more specific feature of aging
      aspects of aging in muscle and nerve rel-          cludes about 100 muscle fibers, where calf      muscles is not clear. Secondly, muscle fi-
      evant to these issues.                             and thigh muscle motor units include            bers may actually transform from Type 2
                                                         1000-2000.4 In addition to transmitting         to Type 1 as a result of the denervation
      SARCOPENIA                                         electrical excitation, each motor neuron        and reinnervation that follows loss of
            Saracopenia refers to the degenera-          provides trophic support to the muscle fi-      motor neurons.6
      tive loss of muscle mass and strength with         bers in its motor unit. Once a muscle fi-             The predominance of Type 1 fiber
      increasing age. It begins in mid-life and          ber loses its nerve input, it undergoes at-     contraction in aging muscles inhibits the
      accelerates significantly in the seventh           rophy unless connection with another            ability to make quick, forceful move-
      and eighth decades. Both active and sed-           nerve terminal can be restored.                 ments. This poses particular problems for
      entary individuals suffer sarcopenia,                                                              rapid postural reflexes important in main-
      though it is worsened by inactivity.                  Growth hormone                               taining balance. In addition to overall
      Muscle mass decreases earlier in women                                                             muscle weakening and proprioceptive
      but men experience greater overall loss,             supplementation                               deficits (described below), slowing of
      averaging 30-40% of their muscle mass
      by age 80.1
                                                                has not                                  postural adjustments presents a major risk
                                                                                                         for falls in the elderly.
            The causes of sarcopenia are mul-                demonstrated
      tiple. They include loss of muscle cells as           improvement in                               THERAPEUTIC CONSIDERATIONS FOR
      well as hormonal changes that influence                                                            THE AGING NEUROMUSCULAR SYSTEM
      the growth and regeneration of differ-                muscle mass or                                    The literature regarding testosterone
      ent cells within muscles. In addition, de-
      generation of spinal motor neurons has a
                                                           strength in elderly                           replacement for sarcopenia presents a
                                                                                                         mixed picture. Meta-analyses have sug-
      profound effect on the muscles they in-               men or women.                                gested that injected testosterone can pro-
      nervate.1,2                                                                                        duce a moderate increase in muscle mass
            Satellite cells are essentially stem cells        Anatomical and physiolgical studies        and strength in older men.7 Concerns
      residing in muscle. In response to physi-          have shown that the number of motor             over adverse effects temper any current
      cal trauma or even vigorous exercise, sat-         units (i.e. the number of spinal motor neu-     enthusiasm. In particular, no large, pro-
      ellite cells proliferate to form new muscle        rons) supplying limb muscles remains fairly     spective studies have looked at rates of
      fibers or fuse with damaged fibers to re-          constant up to age 60. Beyond that,             prostate cancer in older men receiving
      pair them. Most studies have shown re-             healthy individuals typically lose about half   testosterone supplementation. 8
      duction in the number of satellite cells           of their motor units between ages 60 and             Growth hormone supplementation
      with aging. This, along with changes in            80.5 Sprouting of terminal axons from           has not demonstrated improvement in
      growth factor and hormone levels, de-              remaining motor neurons initially com-          muscle mass or strength in elderly men
      creases the regenerative capacity of               pensates for those that are lost, however as    or women. Furthermore, the addition of
      muscle over time.3                                 this process continues, muscle fibers are       growth hormone to a resistance exercise
            Testosterone (T), growth hormone             inevitably left to atrophy without nerve        program does not appear to confer addi-
      (GH) and insulin-like growth factor (IGF)          supply. This neurogenic atrophy is likely       tional benefit. Adverse effects including
      all regulate protein synthesis within muscle..     the major cause of sarcopenia.1,2               carpal tunnel syndrome, hyperglycemia,
      IGF appears to increase synthesis of actin                                                         edema and orthostatic hypotension led
      and myosin (the principal contractile pro-         CHANGES     IN MUSCLE DYNAMICS                  to high drop-out rates in treatment
      teins in muscle), while GH and T promote               Two major types of motor units can          groups of some studies.2
      protein stability. Decreasing levels for all       be distinguished by their morphologic                Relatively few clinical trials have
      three of these hormones in mid to late life        and physiologic characteristics. In Type        evaluated the muscular effects IGF-1
      presumably contribute to sarcopenia. The           1 motor units, small motor neurons in-          administration. A study assessing a two
month course of IGF-1 complexed to a            seen in the elderly. Though neuropathy                        7. Ottenbacher KJ, Ottenbacher ME, et al. Andro-
                                                                                                                  gen treatment and muscle strength in elderly men.
bindng protein, found that grip strength        in older individuals is not frequently re-
                                                                                                                  J Am Geriatr Soc 2006;54:1666-73.
improved by 11%. 9 The effect of estro-         versible, simple preventive measures in-                      8. Brand TC, Canby-Hagino E, Thompson IM. Tes-
gen replacement on sarcopenia has also          cluding use of a cane, nightlights and                            tosterone replacement therapy and prostate can-
received little study to date. Reported         shower chairs should not be neglected.                            cer. Curr Urol Rep 2007;8:185-9.
                                                                                                              9. Boonen S, Rosen C, et al. Musculoskeletal effects
effects of estrogen on lean body mass
                                                                                                                  of the recombinant human IGF-1/IGF binding
have been mixed and changes in strength         NEUROPATHIC PAIN                                                  protein 3 complex in osteoporotic patients with
or contraction speed have yet to be in-               The age-related changes discussed                           proximal femoral fracture. J Clin Endocrinol Metab
vestigated.10                                   above concern the largest sensory fibers.                         2002;67:1593-9.
                                                                                                              10. Thorneycroft JH , Lindsay R, Pickar JH. Body
      Exercise, in the form of resistance       Evaluation of small caliber sensory fibers                        composition during treatment with conjugated
training, appears to be the most effective      is more challenging but crucial to under-                         estrogens with and without medroxyprogesterone
treatment to counteract muscular decline        standing neuropathic pain. This is an                             acetate. Am J Obstet Gynecol 2007;197:e1-7.
in the elderly. Resistance training pro-        important issue for aging populations                         11. Resnick HF, Vinik AI, et al. Age 85+ years acceler-
                                                                                                                  ates large-fiber peripheral nerve dysfunction J
grams can achieve the same percentage           given the striking predominance of cer-                           Gerontol Med Sci 2001;56:M25-M31.
gain in muscle mass and strength at age         tain neuropathic pain conditions in the                       12. Richardson JK, Hurvitz EA. Peripheral neuropa-
80 as they do in young adults.2 Although        elderly. 13                                                       thy. J Gerontol Med Sci 1995; 50:M211- M215.
the mechanism is not understood, resis-               In contrast to the clear age-related loss               13. Hall GC, Carroll D, et al. Epidemiology and treat-
                                                                                                                  ment of neuropathic pain. Pain 2006;122:156-62.
tance training also increases whole muscle      of large sensory fibers, anatomic studies                     14. Lauria G, Holland N, et al. Epidermal innerva-
contraction speed with an associated im-        have demonstrated relative preservation of                        tion. J Neurol Sci 1999;164:172-8.
provement in balance.                           small-caliber, pain sensing fibers in the eld-                15. Baron R, Haendler G, Schulte H. Afferent large
                                                                                                                  fiber neuropathy predicts the development of
      This likely reflects adaptive coordi-     erly.14 This raises an interesting possibility
                                                                                                                  postherpetic neuralgia. Pain 1997; 73:231-8.
nation among different motor units since        regarding the development of post-her-
the contraction speed of individual             petic neuralgia, a condition which is rare                          George M. Sachs, MD, PhD, is Asso-
muscle fibers may actually decrease with        below the age of 50 but complicates 20-                       ciate Professor (Clinical) of Neurology, The
resistance training.                            40 % of zoster cases past the age of 60.                      Warren Alpert Medical School of Brown
                                                Studies testing sensory function in patients                  University.
AGING IN PERIPHERAL SENSORY                     with post herpetic neuralgia have indicated
NERVES                                          that vibratory sensory loss (presumably                       Disclosure of Financial Interests
     Signs of peripheral sensory loss be-       due to large-fiber failure) is more promi-                          The author has no financial inter-
come increasingly prevalent with advanc-        nent than small-fiber (pain and tempera-                      ests to disclose.
ing age. Loss of ankle reflexes and decreas-    ture) deficit.15 This suggests that prefer-                         Discussion of off-label usage of any
ing distal vibration sense are particularly     ential large fiber loss with aging may be                     products or services
common. One study revealed that at least        an important risk factor for the develop-                           *use of supplemental testosterone,
one of these deficits occurred in 26% of        ment of neuralgias and neuropathic pain.                      growth hormones and IGF-1 to reduce
individuals aged 74-84 and in 54% of            If small sensory fibers are relatively pre-                   sacropenia is investigational
those older than 85.11 Correspondingly,         served, they may present an important tar-
anatomic studies have documented lower          get for treatments. The use of local or topi-                 CORRESPONDENCE
numbers of sural nerve fibers and physi-        cal agents aimed at small fibers could                        George M. Sachs, MD, PhD
ologic studies have shown lower ampli-          supplement or replace systemic medica-                        593 Eddy St., APC 689
tudes of sural nerve response in “normal”       tions that are limited by adverse reactions                   Providence, RI 02903
older individuals.                              in elderly patients.                                          e-mail:
     Since these findings are so common,
they are often considered part of “nor-         REFERENCES
mal aging.” This notion overlooks the           1. Thomas DR. Loss of muscle mass in aging. Clin
                                                   Nutrition 2007;26:389-99.
impact of peripheral sensory deficits on
                                                2. Borst SE. Interventions for sarcopenia and muscle
balance and gait in the elderly. A num-            weakness in older people. Age Ageing 2004;
ber of studies have documented that pe-            33:548–55.
ripheral sensory loss is an important risk      3. Shefer G,Van de Mark DP, et al. Satellite-cell pool size
                                                   does matter. Development Biol 2006;294:50-66.
factor for falls. In some studies, the exist-   4. Feinstein B,Lindegard E, Nyman E. Morpho-
ence of lower extremity neuropathy in-             logical studies of human motor units in normal
creased the frequency of falls about 20-           human muscles. Acta Anat 1955; 2:127-39.
fold.12 Even modest loss of propriocep-         5. Doherty TJ, Vandervoort AA, Brown WF. Ef-
                                                   fects of aging on the motor unit. Can J Appl Physiol
tion can pose significant risk when com-           1993;18:331-58.
bined with slowed muscular response and         6, Doherty TJ. Aging and sarcopenia. J Appl Physiol
visual or vestibular disturbances so often         2003;95:1717-27.

                                                                                                                        VOLUME 91           NO. 5      MAY 2008
                                      Sleep Disorders In the Elderly
                                                            Jean K. Matheson, MD

      Older patients frequently complain of         as sleep apnea and periodic leg move-               ity of sleep disordered breathing
      difficulty initiating sleep, sleep mainte-    ments as described below.                       Respiratory Effort Related Arousal: When
      nance or excessive daytime sleepiness,                                                            airway resistance increases, oxygen
      while bed partners or caretakers are dis-     SLEEP- RELATED BREATHING                            saturation and airflow may stay the
      traught by episodes of nocturnal confu-       DISORDERS (SRBDS)                                   same as respiratory effort increases to
      sion or belligerence.                               The most important cause of sleep dis-        overcome obstruction. This increased
           Sleep disorders may represent a pri-     ruption is sleep-disordered breathing. The          respiratory effort may induce an
      mary disorder of mechanisms regulating        term “sleep-disordered breathing” prima-            arousal that disturbs sleep termed,
      sleep or failure of a specific organ system   rily refers to the sleep apnea syndromes, but       RERA, respiratory effort- related
      manifesting in a unique way during sleep.     also includes disorders that result in noc-         arousal. This event is NOT recognized
      Sleep complaints should not be ignored        turnal hypoventilation and hypoxemia such           by CMS and is sometimes called a
      or treated empirically with pharmaco-         as restrictive and parenchymal pulmonary            “hypopnea without desaturation”.1
      logic agents without analysis of the etiol-   diseases. While well known to cause exces-
      ogy.                                          sive daytime sleepiness, the sleep apnea syn-          The presence of 5 apneas/hour of
                                                    dromes, both central and obstructive, are       sleep was previously deemed necessary to
      POLYSOMNOGRAPHY                               also important contributors to difficulty       establish the presence of either “obstruc-
           Polysomnography is the term ap-          initiating and maintaining sleep because of     tive sleep apnea” or “central sleep apnea”.
      plied to the simultaneous and continu-        frequent nocturnal arousals. Current defi-      It is now clear, however, that either in-
      ous measurement of multiple physiologic       nitions that have the most widespread clini-    complete obstructions or central
      parameters during sleep. In practice, the     cal use are based on guidelines provided        hyoventilatory episodes without apnea
      polysomnogram (PSG) has come to               by the Center for Medicare and Medic-           induce physiologic changes of the same
      mean a specific type of polysomnographic      aid Services (CMS);2                            magnitude as apneas. CMS currently
      study in which measurements allow for                                                         accepts a minimum AHI of 5 as evidence
      1) the identification of sleep stage, 2)      Apnea: An apnea is defined as the ab-           of sleep apnea that justifies treatment.
      monitoring of cardio-pulmonary func-             sence airflow for at least 10 seconds.       However, RERAs, often occult contribu-
      tion and 3) monitoring of body move-             There are three types:                       tors to sleep disruption, are not included
      ments during sleep.                           Obstructive apnea: Absence of airflow           in the CMS definition of sleep apnea, but
                                                       for at least 10 seconds with evidence        are accepted by the American Academy
      SLEEP STAGING      AND   ARCHITECTURE            of persistent respiratory effort.            of Sleep Medicine as determinants of
           Rapid eye movement (REM) sleep,          Central apnea: Absence of airflow for           obstructive sleep apnea syndrome. 4
      sometimes called dreaming sleep, and             10 seconds without evidence of any                  Well-documented risk factors for ob-
      non-REM (NREM) sleep are the two                 of respiratory effort.                       structive sleep apnea include obesity, large
      sleep states. NREM and REM sleep alter-       Mixed Apnea: Absence of airflow for             neck, upper airway structural abnormali-
      nate in recurring cycles of approximately        10 seconds with initial absence of           ties, nasal congestion, endocrine abnormali-
      90 minutes. NREM sleep had been di-              effort followed by a return of respi-        ties, muscular weakness and sedating drugs.
      vided into four stages (1-4), representing       ratory effort before resumption of                  In aging and degenerative neurologi-
      progressive deepening of sleep. A recent         airflow.                                     cal disease there are additional risk factors
      revision of staging nomenclature now          Hypopnea: The term hypopnea refers to a         including laryngeal dysfunction and cen-
      identifies these stages as N1, N2 and N3.1       decrease in airflow. By CMS criteria:        trally- induced dysynergy of upper airway
           In what has been thought to be              “Hypopnea in adult patients is defined       muscle activation in relationship to chest
      normal aging nocturnal awakenings                as an abnormal respiratory event last-       wall and diaphragmatic activation.
      and wake time increase. N3 sleep de-             ing at least 10 seconds with at least a             Central sleep apnea episodes usually
      creases and REM time usually remains             30% reduction in thorocoabdominal            represent Cheyne-Stokes breathing, a cre-
      relatively constant. Stage one sleep in-         movement or airflow as compared to           scendo-decrescendo breathing pattern,
      creases as a reflection of sleep disrup-         baseline, and with at least a 4% oxy-        common in the elderly, especially those
      tion. Sleep efficiency, the ratio of time        gen desaturation.”2                          with congestive heart failure. Periods of
      asleep to time in bed, decreases second-      Apnea Hypopnea Index (AHI): The                 central apnea or hypopnea predispose to
      ary to both increased time in bed and            total number of apneas and                   obstruction as well, because low airflow
      increased wake. However, many of                 hypopneas are summed and divided             contributes to airway collapse. This type
      these changes attributed to “normal”             by the number of hours of sleep.             of breathing abnormality, once consid-
      aging may also be exacerbated or in-             When used with the definitions               ered benign, may markedly disrupt
      duced by what we now know to be com-             above, the index is useful as a stan-        sleep. 4
      mon and treatable sleep disruptors such          dardized measure that reflects sever-
TREATMENT OF SLEEP-DISORDERED                   that disturb sleep (PLMS). Many medi-              tation refers to the development of symp-
BREATHING:                                      cations are implicated in the induction            toms earlier in the day with increasing se-
      Continuous positive airway pressure       of periodic and aperiodic leg move-                verity, further exacerbated by dosage in-
(CPAP) is the mainstay of treatment for         ments, most commonly SSRIs, SNRIs                  creases. This phenomenon occurs most dra-
obstructive sleep apnea and for some pa-        and tricyclic antidepressants.                     matically with the use of levodopa and less
tients with predominantly central apnea.                                                           frequently with the dopaminergic agonists
Airway pressure acts as a pneumatic splint      Restless Legs Syndrome                             ropinirole and pramipexole. Gabapentin
to maintain upper airway patency during               Restless legs syndrome (RLS) is char-        and low dose opioids are useful second line
sleep. Bi-level positive pressure (BIPAP) is    acterized by 1) an urge to move accompa-           drugs that can be used alone or in combi-
often better tolerated in the elderly because   nied by uncomfortable sensations, predomi-         nation with dopaminergic agonists for dos-
it provides an expiratory pressure always       nantly in the legs, that are 2) relieved by        age sparing. Benzodiazepines are third line
lower than inspiratory pressure, making         movement, 3) occur when sedentary and 4)           drugs because of limited efficacy and the
expiration more natural and less effortful.     are worse in the evening.5 This syndrome is        development of tolerance.
The inspiratory–expiratory pressure differ-     closely associated with PLMD. Restless legs
ence also acts to augment ventilation in dis-   syndrome, however, is a syndrome based on          REM Behavior Disorder
orders associated with hypoventilation.         clinical, not polysomnographic criteria. The             Low muscle tone observed on PSGs
New devices termed servo-ventilators are        disorder is familial in approximately 50% of       during REM correlates with the normal
based on bi-level positive pressure technol-    cases. Prevalence estimates vary between 5         paralysis that occurs during dreaming. This
ogy, and can be used at home to treat pa-       and 20% of the general adult population in         temporary paralysis, termed REM sleep
tients with central components of their         North America and the disorder appears to          atonia, prevents the dreaming subject
sleep-disordered breathing, especially          increase with age.5 Abnormalities of both          from enacting dreams. REM Behavior
Cheyne-Stokes respirations. These devices       dopamine and iron metabolism are impli-            Disorder is characterized by incomplete
are an important addition to the treatment      cated in the underlying pathophysiology.           REM atonia associated with motoric acti-
of sleep-disordered breathing in heart fail-    Iron deficiency is known to exacerbate or          vation during dreams.7) Typically the pa-
ure. Many new mask styles and variations        precipitate restless legs and periodic leg move-   tient, bed partner, or caretaker complains
on these devices including “smart” auto ti-     ments in familial and non-familial cases. Sec-     of violent, often injurious, activity during
trating machines can improve patient tol-       ondary causes of RLS are subject to some           sleep. The patient may complain of a
erance dramatically. Full face masks are        debate due to limited data and include ure-        change in dream content with violence
now comfortable and useful in patients who      mia, neuropathy, and medications, especially       and running as typical themes. Sometimes
may have rejected positive pressure previ-      anti-dopaminergic drugs and SSRIs.                 the patient is able to incorporate ongoing
ously because of nasal obstruction.3                                                               conversation and activity into the dream,
      Cheyne-Stokes respirations often re-      Management of Restless Legs                        giving rise to the misperception that he is
spond to low-flow oxygen delivered              and Periodic Limb Movements                        confused or hallucinating until he sud-
through nasal prongs that generally are               Periodic leg movements are often             denly awakens and appear to “clear” his
better tolerated than positive pressure. O2     found incidentally on sleep studies and are        mental status. Underlying dementia or
tends to decrease over-responsiveness to        not generally treated unless they are either       acute illness may impair the patient’s abil-
CO2 that perpetuates the hyperventilation-      accompanied by symptomatic restless legs,          ity to report the perception of dreaming,
apnea cycle. Obstructive episodes exacer-       or clearly contribute to arousals. Recom-          resulting in misdiagnosis. Hospital care-
bated by central apneas may also improve.       mendations for the management of restless          takers usually dismiss even detailed dream-
Sedating medications, especially hypnotics      legs have recently been published.6 Serum          ing reports as confusion. The disorder is
and narcotics, can exacerbate sleep disor-      ferritin should be checked in all patients;        frequently mistaken for “sundowning” or,
dered breathing and are best avoided when       iron replacement is recommended in pa-             because of the violent quality of the
sleep-disordered breathing is suspected.3       tients with ferritins below 45-50 ug/ml.           dreams, post-traumatic stress disorder.
                                                Response to iron replacement may not oc-                 REM behavior disorder occurs most
SLEEP RELATED MOVEMENT                          cur in all patients and usually takes months       frequently in older men with a mean age
DISORDERS                                       to years; some clinicians advocate intrave-        of 60. Over time it has become clear that
     Sleep-related movement disorders           nous replacement in severe cases. Because          RBD precedes other clinical signs or symp-
include conditions in which simple ste-         antidepressant and antihistamine medica-           toms of some degenerative diseases, espe-
reotyped movements are present during           tions may exacerbate restless legs they            cially Parkinson’s disease, dementia with
sleep and induce sleep disruption. Diffi-       should be avoided if possible. Some clini-         Lewy bodies and multisystem atrophy, (the
culty initiating and/or maintaining sleep       cians routinely screen for neuropathy with         “synucleinopathies.”) by years. Conversely,
are the typical complaints.                     exam and metabolic studies. Ropinirole             the prevalence of RBD in Parkinson’s dis-
                                                (Requip) and pramipexole, (Mirapex), both          ease is in the range of 33-60%. The com-
Periodic Limb Movement Disorder                 dopaminergic agonists FDA approved for             bination of degenerative dementia and
     The most prevalent of these disor-         RLS, are markedly effective. Because of the        RBD is highly correlated with the diag-
ders is periodic limb movement disor-           possibility of inducing a syndrome termed          nosis of dementia with Lewy bodies, based
der (PLMD), characterized by periods            “augmentation”, it is best to use as low a         on clinical and pathologic criteria. There
of repetitive stereotyped leg movements         single evening dose as possible. Augmen-           are rare published reports of RBD with a
                                                                                                           VOLUME 91       NO. 5    MAY 2008
      “tauopathy” (e.g. pure Alzheimer’s disease,      REFERENCES                                                       Jean K. Matheson, MD, is Neurologi-
      frontotemporal dementia, progressive su-         1. The AASM manual for the scoring of sleep and            cal Medical Director, Sleep Disorders Cen-
                                                          associated events. Westchester, IL: American Acad-
      pranuclear palsy). Some medications, es-                                                                    ter, Beth Israel Deaconess Medical Center,
                                                          emy of Sleep Medicine, 2007.
      pecially NSRIs and SSRIs are known to            2. Medicare National Coverage Determinations               and Associate Professor of Neurolog y,
      precipitate and exacerbate the disorder.            Manual Chapter 1, Part 4 Section 240.4. http://         Harvard Medical School.
      Idiopathic RBD also exists.7              
                                                       3. Kryger MH, Roth T, Dement WC. Principles and
                                                                                                                  Disclosure of Financial Interests
      Circadian Rhythm Disorders:                         Practice of Sleep Medicine. 4th ed. Philadelphia,             The author has no financial inter-
      Advanced Phase Sleep Disorder                       PA: Elsevier/Saunders, 2005.                            ests to disclose.
            The tendency for elderly patients to       4. The international classification of sleep disorders           Discussion(s) of off-label usage of any
                                                          : Diagnostic & coding manual, ICSD-2. 2nd ed.
      spend more time asleep during the day               Westchester, IL: American Academy of Sleep              products or services: gabapentin for rest-
      and less time asleep at night raises the pos-       Medicine, 2005.                                         less legs syndrome, clonazepam for REM
      sibility that neurological dysfunction of the    5. Allen RP Picchietti D, et al. Restless legs syndrome:
                                                                   ,                                              Behavior Disorder
      biologic clock within the suprachiasmatic           Diagnostic criteria, special considerations, and epi-
                                                          demiology. A report from the restless legs syn-
      nucleus of the hypothalamus mediates                drome diagnosis and epidemiology workshop at            CORRESPONDENCE
      these changes. Advanced phase sleep dis-            the National Institutes of Health. Sleep Med            Jean K. Matheson, MD
      order is a well-recognized circadian disor-         2003;4(2):101-119.                                      Sleep Disorders Center, CCE866
                                                       6. Silber MH, Ehrenberg BL, et al. An algorithm for
      der in which patients complain of diffi-                                                                    Beth Israel Deaconess Medical Center
                                                          the management of restless legs syndrome. Mayo
      culty staying awake in the evening and              Clin Proc 2004;79:916-22.                               330 Brookline Ave
      early morning awakening.5 This disorder          7. Boeve BF, Silber MH, et al. Pathophysiology of          Boston MA 02215
      is common in the elderly and may be mis-            REM sleep behaviour disorder and relevance to           Phone: (617) 667-4307
                                                          neurodegenerative disease. Brain 2007.
      taken for early morning insomnia.                                                                           e-mail:
                                                       8. Campbell SS, Dawson D, Anderson MW. Alle-
            Phase advance is exacerbated by vi-           viation of sleep maintenance insomnia with timed
      sual impairment and low light exposure              exposure to bright light. J Am Geriatr Soc
      during the day; evening light exposure              1993;41:829-36.
      can therapeutically delay rhythms and
      improve sleep maintenance.8

                                  Driving Safety Among Older Adults
                                                 Melissa M. Amick, PhD, and Brian R. Ott, MD

      The number of individuals in the United          driving tests compared to their non-de-                    While performance on neuropsychologi-
      States who are age 65 and older is expected      mented counterparts. 4 For example,                        cal measures does predict driving abilities,
      to double by 2030.1 As this population in-       Duchek and colleagues found that 43%                       our research has found that PD drivers are
      creases, so will the number of licensed older    of participants with mild Alzheimer’s dis-                 infrequently observed to be unsafe drivers:
      drivers. Increasing age is a significant risk    ease (AD) failed the road test, compared                   only one of 25 participants assessed actu-
      factor for unsafe driving. The risk for crash    to 13% of patients with very mild AD and                   ally failed our road test. Rather, most par-
      involvement increases dramatically after the     3% of non-demented control participants.3                  ticipants received marginal or safe ratings.5
      age of seventy; and drivers 85 and older         Longitudinal data indicated that patients                  Research in dementia and Parkinson’s dis-
      have the highest driver fatality rate.2 Driv-    with mild AD experienced a more rapid                      ease emphasizes that mild degrees of motor
      ers over the age of 70 have the highest an-      decline in driving skills compared to the                  slowing, cognitive dysfunction, and changes
      nual fatality rate per miles driven compared     control group; however, patients with very                 in vision may not adversely affect driving
      to all age groups, except those aged 25 and      mild AD did not differ significantly from                  skills, and that these diagnoses alone are not
      younger.2 In a study of mild dementia and        either group.3 Comparing crash rate                        absolute indicators of unsafe driving.
      non-demented drivers, baseline age signifi-      records collected by the state registries, only                  The American Medical Association’s
      cantly predicted performance on a road test      one study has observed that patients with                  Physician’s Guide to Assessing and Coun-
      independent of cognitive status.3 These          dementia are more frequently involved in                   seling Older drivers lists acute medical
      findings suggest that, as older people age,      accidents compared to a control group.4                    events such as myocardial infarction, stroke,
      the risk of unsafe driving increases, and care        There is also concern about the driv-                 syncope, seizure, surgery, and delirium as
      providers will need to monitor their aging       ing skills of patients with Parkinson’s dis-               well as chronic conditions such as disease
      patients’ driving safety.                        ease (PD), because of the motor and non-                   affecting vision, cardiovascular disease, neu-
            Research on driving safety in the eld-     motor symptoms (visual changes and cog-                    rological disorders, psychiatric illnesses,
      erly has mainly focused on drivers with de-      nitive dysfunction). Interestingly, motor                  metabolic conditions, musckuloskeletal
      mentia, who consistently perform more            symptom severity and visual functioning do                 impairments, and respiratory disease as risk
      poorly on open road tests and simulated          not consistently predict driving skills.5                  factors for unsafe driving.6 Detailing the
specific conditions that may be associated       accidents and traffic violations, whereas less    or at home physical therapy exercises) and
with unsafe driving is beyond the scope of       accurate raters emphasized dementia his-          vision interventions (speed of information
this brief review. Interested readers are        tory, global neuropsychological perfor-           processing training or at home exercises to
referred to chapter 2 of the AMA’s guide.        mance, eye examination results, general           improve visual perception) were reported.10
                                                 medical history, and language skills9. Taken      Educational programs were associated with
OFFICE BASED ASSESSMENTS               FOR       together, these findings suggest that driv-       some improvements in driving safety be-
DRIVING SAFETY                                   ing safety is best not determined by perfor-      haviors.10 Unfortunately the two studies (self
      In a sample of 460 primary care phy-       mance on a single measure, but rather             monitoring program and California’s ma-
sicians in Canada approximately 72% in-          based on consideration of many patient            ture drivers program) that examined the
dicated that physicians should be legally        characteristics. Importantly, compared to         benefit of driver education programs upon
responsible for reporting unsafe drivers to      physical examinations or neuropsychologi-         crash rates found no significant effect.10.
state licensing authorities.7 Strikingly, only   cal tests, a road test conducted by a profes-          The limited research should not com-
55% of the surveyed physicians believed          sional driving instructor or certified occu-      pletely dissuade clinicians from recom-
they were most qualified to make this de-        pational therapist appears to be the gold         mending these “refresher courses” to their
cision, and 88% felt that they would ben-        standard for determining driving safety.          older drivers. Driver education programs
efit from additional training in this area.7                                                       can help individual drivers, and some in-
The AMA’s guide recommends that phy-                                                               surers provide discounts to older adults who
sicians assess visual function (acuity and
                                                      …a road test                                 participate in AARP’s driver reeducation
visual fields), cognition (Clock drawing            conducted by a                                 program. Until these programs are empiri-
test and Trails B, a visual motor task re-                                                         cally validated, however, it is difficult to
quiring participants to alternate between
                                                  professional driving                             judge their relative benefit as well as which
connecting numbers and letters) and mo-          instructor or certified                           elements of the course are associated with
tor function (20 foot walk and manual test                                                         the best remediation of driving skills.
of range of motion and motor strength),
with cutoff scores for each measure.6             therapist appears to CESSATION OF DRIVING
      While office-based tests can assist cli-
nicians in making recommendations about
                                                 be the gold standard states’The AMA Guide has compiledrefer-
                                                                               reporting procedures for easy

driving safety, some have argued that there         for determining                                     6
                                                                         ence. In Rhode Island “Any physician who
is not enough research linking these mea-                                diagnoses a physical or mental condition
sures to unsafe driving. For example,
                                                     driving safety.     which, in the physician’s judgment, will sig-
Molnar and colleagues performed a system-                                                          nificantly impair the person’s ability to safely
atic review of research studies (1984-2005)      OLDER DRIVER RE-EDUCATION                         operate a motor vehicle may voluntarily re-
examining the predictive utility of office-            Changes in sensory, motor, or cogni-        port the person’s name and other informa-
based screening measures for determining         tive functioning do not always mean that          tion relevant to the condition to the medical
driving safety.8 They found only sixteen ar-     the older patient should retire from driv-        advisory board within the Registry of Mo-
ticles were of high enough quality to include    ing. In some cases evaluation and training        tor Vehicles. Any physician reporting in good
in the review and only one study provided        by an occupational therapist or private driv-     faith and exercising due care shall have im-
cutoff scores for determining driving safety.    ers’ education program may help older             munity from any liability, civil or criminal.
The review indicated that Trails B was vari-     adults become safe drivers again. Modifi-         No cause of action may be brought against
ably related to driving performance; and         cations can be made to vehicles to make           any physician for not making a report.”6
none of the studies examined clock-draw-         them easier to use. For example, older adults     Massachusetts is a self-reporting state. It is
ing performance. At the present time clini-      with limited range of motion in their necks       the responsibility of the driver to report to
cians are expected to make recommenda-           may benefit from parabolic mirrors. Driv-         the Registry of Motor Vehicles any medical
tions, without empirical evidence to sup-        ers with limited motion in their arms may         condition that may impair driving ability.
port office-based assessments.                   need a knob on their steering wheel.              However, physicians are encouraged to re-
      Ott and colleagues examined the ac-              The most common driving re-educa-           port unfit drivers to the Registry of Motor
curacy of physician assessments (based on        tion program is the AARP Driver Safety            Vehicles. The law does not provide any pro-
chart review) for determining a professional     Program, which is run as a classroom course       tection from liability, nor does it promise con-
driving instructor’s rating of AD patients’      and available on-line. AAA and state agen-        fidentiality due to the “Public Records” law
standardized road test performance.9 Phy-        cies also offer informational materials as well   which states simply that a driver is entitled
sicians’ accuracy ranged from 62% to 78%.9       as classroom education. Research on the           to any information upon receipt of written
Clinicians also indicated which portions of      benefits of older driver re-education is very     approval” 6 pg30-31.
the evaluation they relied upon for making       limited. Kua and colleagues performed a                 Clinicians who recommend driving ces-
their decision.9 Raters with higher accuracy     systematic review of the older drivers re-        sation to their patients should suggest alter-
emphasized dementia duration, dementia           education literature and found that only          native transportation. In Rhode Island patients
severity (CDR and MMSE), neuropsycho-            eight studies demonstrated sufficient inter-      can be referred to the Department of Elderly
logical measures of praxis, visuospatial abil-   nal validity to be included.10 Limited ben-       Affairs Pocket Manual of Elder Services,11
ity, executive function, attention, history of   efits of physical (range of motion exercises      which lists the different RIDE programs as
                                                                                                            VOLUME 91        NO. 5     MAY 2008
      well as a phone number to schedule paratansit          test and computerized office tests. For more                     9. Ott BR, Anthony D, et al. Clinician assessment
                                                                                                                                  of the driving competence of patients with de-
      for individuals unable to use public transpor-         information about participation or referrals,
                                                                                                                                  mentia. J Am Geriatr Soc 2005;53:829-33.
      tation. Care providers will want to closely            contact Lindsay Miller at 444-0789.                              10. Kua A, Korner-Bitensky N, et al. Older driver retrain-
      monitor these patients for signs of depression,              A third and final priority is to exam-                         ing. J Safety Res 2007;38:81-90. Epub 2007 Feb 14.
      self-neglect, and isolation as all can occur as a      ine the benefits of driver education pro-                        11. The Rhode Island Department of Elderly Affairs.
                                                                                                                                  Pocket Manual of Elder Services. http://
      result of loss of driving privileges (see the AMA      grams. If physicians are going to recom-                             w w w. d e a . s t a t e . r i . u s / d o c u m e n t s /
      guide for specific monitoring methods). 6              mend these interventions, as with any other                          2007%20Pocket%20Manual.pdf
                                                             treatment, efficacy trials are necessary.
      FUTURE DIRECTIONS                                                                                                            Melissa Amick, PhD, is Staff Neuropsy-
            There is much research to be done in             REFERENCES                                                       chologist, Memorial Hosiptal of RI, and Clini-
      the area of assessing older driver safety. As          1. US Interim Projections by Age, Sex, Race, and His-            cal Assistant Professor, The Warren Alpert
                                                                panic Origin. Table 2a. Projected Population of the
      Molnar and colleagues point out, the estab-               United States, by Age and Sex: 2000 to 2050. http:/           School of Medicine at Brown University.
      lishment of empirically validated cut scores              /                             Brian R. Ott, MD, is Director, The
      for visual functioning, motor skills, and cog-         2. US Department of Transportation National High-                Alzheimer’s Disease & Memory Disorders
      nition is necessary to help physicians confi-             way Traffic Safety Administration. Traffic Safety             Center, Rhode Island Hospital, and Profes-
                                                                Facts 2000.
      dently identify truly at risk drivers.8                   Pubs/2000OLDPOP          .PDF                                 sor, Department of Clinical Neurosciences,
            A second priority is to establish clini-         3. Duchek JM, Carr DB, et al. Longitudinal driving               The Warren Alpert Medical School of
      cally meaningful outcome measures. Cer-                   performance in early-stage dementia of the Alzheimer          Brown University.
                                                                type. J Am Geriatr Soc 2003;51:1342-7.
      tainly poor performance on a simulated driv-
                                                             4. Man-Son-Hing M, Marshall SC, et al. Systematic
      ing test or pre-determined driving route is               review of driving risk and the efficacy of compen-            Disclosure of Financial Interests
      an indication for concern and monitoring,                 satory strategies in persons with dementia. J Am                    The authors have no financial inter-
      but there is not a perfect correlation between            Geriatr Soc 2007;55:878-84.                                   ests to disclose.
                                                             5. Amick MM, Grace J, Ott BR. Visual and cognitive
      these measures and crash risk. In this regard,
                                                                predictors of driving safety in Parkinson’s disease
      a new study examining risk factors for poor               patients. Arch Clin Neuropsychol 2007;22:957-67.              CORRESPONDENCE
      drivers in a naturalistic setting has begun at         6. The American Medical Association. Physician’s Guide           Melissa M. Amick, PhD
      Rhode Island Hospital. In this study, funded              to Assessing and Counseling Older Drivers. http://            Memorial Hospital of RI
      by the National Institute of Health, older             7. Jang RW, Man-Son-Hing M, et al.
                                                                                                                              Department of Medical Rehabilitation
      drivers both with and without dementia will               Family physicians’ attitudes and practices regard-            111 Brewster Street
      be examined by video camera recordings in                 ing assessments of medical fitness to drive in older          Pawtucket RI, 02860
      their own cars and driving in their neigh-                persons. J Gen Intern Med 2007;22:531-43.                     Phone: (401) 729-2326
                                                             8. Molnar FJ, Patel A, et al. Clinical utility of office-based
      borhoods. These recordings will be com-                   cognitive predictors of fitness to drive in persons with
      pared to performance on a standardized road               dementia. J Am Geriatr Soc 2006;54:1809-24.

              Geriatric Neurorehabilitation In the New Millenium
                                                                       Stephen T. Mernoff, MD

      Rehabilitation interventions have changed              need inpatient rehabilitation. Medicare re-                      benefit from at least three hours of therapy
      little in the last few decades, aside from im-         cipients comprise 75-80% of admissions to                        per day. Subacute rehabilitation units pro-
      provements in materials and medical care.              acute rehabilitation facilities (ARFs). In                       vide programs for patients who cannot tol-
      Most neurorehabilitation research involves             2007, the average age of patients admitted                       erate, or will not benefit from, more inten-
      geriatric patients since most disabling neu-           to ARFs in the US was 67 years. After an                         sive therapy. Home therapy may often be
      rologic disease occurs in older populations.           average stay of 16 days,1 73% of these pa-                       suboptimal due to lack of equipment and
      Proving rehabilitation intervention efficacy           tients returned home. With limited staffing                      inefficient scheduling. Outpatient therapy
      is difficult for methodological reasons.               and ill patients, acute care hospitals usually                   varies between one and five sessions a week
             New technologies and neuroscience ad-           provide one or two brief therapy treatments                      for medically stable patients. Patients may
      vances allow us to foresee development of evi-         a day. Immobilization for even only a few                        move between these settings, depending on
      dence-based neurorehabilitation interventions          days causes deconditioning which takes                           medical status and rehabilitation needs.
      improving functional outcomes. The need                longer to reverse than to develop; therapy
      for such interventions will increase as the popu-      should be initiated as soon as possible. Long-                   ROLE OF PHYSICIANS IN
      lation ages. Developing patient-specific reha-         term acute care (LTAC) facilities manage                         REHABILITATION
      bilitation programs using selected tools at selected   patients with persistent intensive nursing and                        Primary care physicians and/or
      times during recovery now seems within reach.          medical care needs. Acute rehabilitation hos-                    physiatrists provide general medical manage-
                                                             pitals admit 50-60% of their patients with                       ment and help to prevent complications. Im-
      REHABILITATION SETTINGS                                neurologic diagnoses, generally providing                        mobility increases risks of infection, deep
           Approximately 6-8% of Medicare pa-                the most intensive rehabilitation programs                       venous thrombosis, and skin breakdown,
      tients admitted to acute care hospitals will           available for patients who can tolerate and                      which can usually be effectively prevented.
Inadequate sleep interferes with therapy, pos-      to months, cells in the ischemic penumbra           of an impaired arm leads to preferential use
sibly contributing to cognitive impairments.        recover somewhat. These cells may have              of the unaffected arm.7 CIMT is a “forced
Obesity and depression must be treated early        greater potential for synaptic plasticity via in-   use” paradigm. The use of the unaffected arm
and aggressively. Reassessment of medications       creased expression of genes for neurotrophins       is limited (by a sling or mitt) and the affected
is critical; patients often come to rehabilita-     and angiogenesis.3 The third stage is thought       arm/hand undergoes intense therapy. Mul-
tion on medications they no longer need.            to consist of distant undamaged tissue taking       tiple animal and human studies, including the
      The role of the neurologist has expanded      on the functions of lost tissue. Several mecha-     landmark EXCITE trial, have demonstrated
as patients survive acute neurologic disease at     nisms may subserve neural plasticity includ-        the technique to be quite effective in certain
progressively higher rates and more is known        ing synaptogenesis, axonal regrowth,                populations. There is some evidence that mea-
about neurologic recovery. First and foremost       neurotrophins, and neurogenesis(stem cells).4       surable cortical reorganization results. CIMT
is accurate diagnosis; some patients arrive to            These mechanisms seem to be inhibited         has been investigated mainly in patients with
rehabilitation with incorrect diagnoses. Pa-        in more mature tissue. Enhancing natural            stroke and cerebral palsy, but is also being
tients with traumatic brain injury must be          mechanisms of plasticity may improve recov-         applied to lower limb impairment, traumatic
monitored for hydrocephalus and subdural            ery. For example, antibodies to MAG promote         brain injury, and even aphasia.
hematomas. The neurologist’s role in educat-        axonal regrowth.5 Although motor control is
ing therapists, patient, and family, by describ-    virtually fixed after adolescence, the reorgani-    STROKE INPATIENT REHABILITATION
ing impairments, expected course of recov-          zation occurring in damaged neurologic tissue       REINFORCEMENT OF WALKING
ery, and prognosis, is critical to program de-      may present an opportunity to intervene. Po-        SPEED (SIRROWS)8
sign and realistic goal-setting.                    tential interventions, including neurotrophins,            Gait speed may be a surrogate marker
                                                    stem cells, and pharmacologic potentiation, are     for gait quality, often the major limiting factor
EVOLUTION OF                                        technically challenging and expensive. Elegant,     for home discharge. Faster gait improvement
NEUROREHABILITATION            AS A                 noninvasive, and less expensive methods that        in the inpatient rehabilitation setting might
CLINICAL SPECIALTY2                                 may enhance neural plasticity are being inves-      result in more efficient recovery with shorter
      Rehabilitation Medicine as a medical          tigated. Different approaches will likely be ap-    lengths of stay. The World Federation of
subspecialty, the disciplines of Physical, Oc-      plicable in different situations.                   Neurorehabilitation (WFNR), in collabora-
cupational, and Speech Therapies, and dedi-                                                             tion with the American Society of
cated Rehabilitation Units developed in the         NEW NEUROREHABILITATION                             Neurorehabilitation (ASNR), is running the
early to mid 20th century as a result of war        TECHNOLOGIES UNDER                                  SIRROWS trial to determine if this is true.
injuries (amputations) and polio. The “tradi-       INVESTIGATION                                       This elegant and simple RCT involves giving
tional” rehabilitation model was based on                 Neurorehabilitation research is coming        patients daily feedback about their walking
static impairments and compensation for,            of age. Improvements in outcome measures            speed, with encouragement to walk faster,
rather than restoration of, function. In the        and study design allow new techniques to            safely. SIRROWS is the first attempt to de-
late 20th century, improved survival from           be investigated in the context of random-           velop an internationally controlled multicenter
acute neurologic injury and an emphasis on          ized, controlled, often multi-centered trials       trial in neurorehabilitation. T  wenty centers,
evidence-based practice resulted in improved        (RCTs). The EXCITE trial, a study of Con-           mostly outside of the US, are involved. RHRI
outcome measures and a “neurologic” model           straint-Induced Movement Therapy, dem-              will soon become a SIRROWS study site.
of rehabilitation incorporating pathology and       onstrates that multicenter RCTs for rehabili-
prognosis. Powerful technologies and greater        tation interventions are feasible, and is serv-     “MEDIUM        TECH”     INTERVENTIONS
understanding of plasticity present the possi-      ing as a model for design of future studies.6       Sensory Enhancement
bility of enhancing natural recovery processes            The Center for Restorative and Regen-                Afferent Corporation (Providence, RI) has
and evaluating these techniques. Clinicians         erative Medicine (a collaboration of Brown          several devices under development. Afferent’s
will be able to develop the rehabilitation “holy    University and the Providence VA Medical            technology involves applying subthreshold
grail”: evidence-based patient-specific reha-       Center led by Roy Aaron, MD, and John               mechanosensory stimuli to affected limbs to
bilitation programs using selected techniques       Donoghue, PhD), in collaboration with MIT           enhance afferent information flow to the brain.
at selected times during recovery.                  and Harvard, is becoming a major center for         The premise is that sensory impairment con-
                                                    such research. Other local entities, including      tributes to functional impairment after nervous
MECHANISMS OF           RECOVERY AND                Cyberkinetics, Inc. (Foxboro, MA), Afferent         system injury. Improving sensory function
THE CONCEPT OF          NEUROPLASTICITY             Corporation (Providence, RI), and Rehabili-         could improve recovery by enhancing plastic-
      A brief summary of recovery mecha-            tation Hospital of Rhode Island (RHRI,              ity. Studies show the system to be effective in
nisms in stroke with a three-stage model is in-     North Smithfield), are at the forefront of these    sensory-mediated gait disorders.9 A pilot study,
structive. In the first stage, reduction of edema   efforts. Some of these investigational interven-    using the technology in patients with arm weak-
(causing mass effect and metabolic depression)      tions are briefly described below.                  ness after stroke, is being conducted at
over days to weeks improves the function of                                                             Spaulding Rehabilitation Hospital in Boston.
noninfarcted tissue as intercellular commu-         “LOW     TECH” INTERVENTIONS
nication improves. The second and third stages           Constraint-Induced Movement                    “HIGH TECH” INTERVENTIONS
of recovery are marked by spontaneous neu-          Therapy (CIMT) is based on the concept of           Robotics
rophysiologic adaptations referred to as neu-       “learned nonuse” in monkeys, a behavioral                 Various robotic devices are being stud-
ral plasticity. In the second stage, over weeks     suppression in which lack of success with use       ied for use in rehabilitation settings. The MIT-
                                                                                                                 VOLUME 91        NO. 5     MAY 2008
      MANUS robots, under development over the             that detect and decode brain signals, allow-
      last 15 years at the MIT biomedical engineer-        ing control of external devices. The Braingate      REFERENCES
      ing department, are devices designed to pro-         (Cyberkinetics, Inc, Foxboro, MA) device,           1. and Bazemore, Lisa (eRehab)
                                                                                                                   personal communication 10/17/07.
      vide consistent doses of intense limb exercise.      developed in John Donoghue’s laboratory
                                                                                                               2. Dobkin BH. The Clinical Science of Neurologic Reha-
      They provide decreasing levels of assistance as      at Brown University, is an electrode array              bilitation, 2nd edn. Oxford University Press, 2003
      the patient’s own abilities improve. The devices     implanted on the cerebral cortex. A com-            3. Wei L, et al. Collateral growth and angiogenesis
      also provide kinematic data that measure ef-         puter decodes detected signals to determine             around cortical stroke. Stroke 2001; 32:2179-84.
                                                                                                               4. Kempermann, et al. J Neurosci 2002;22:635-8.
      fectiveness of the technique and give insight        the individual’s intended movements. A pi-
                                                                                                               5. Lehmann M, et al. Inactivation of Rho signaling
      into natural recovery. Initial studies are encour-   lot trial with human subjects has demon-                pathway promotes CNS axon regeneration. J
      aging, and demonstrate improved motor func-          strated that patients can operate cursors on            Neurosci 1999; 19:7537-47.
      tion in involved limbs which appears to be sus-      computer screens with their thoughts,11,12 al-      6. Wolf SL, et al. Effect of CIMT on upper extrem-
                                                                                                                   ity function 3-9 months after stroke. JAMA 2006;
      tained for years after a therapeutic trial of 4-8    lowing control of external devices such as              296:2095-104.
      weeks.10 A VA multicenter trial (supervised by       televisions and robotic arms.                       7. Taub E, et al. Technique to improve chronic motor
      Albert Lo, MD, PhD, of the Providence VA)                  A less invasive device, the Wadsworth             deficit after stroke. Arch PM&R 1993; 74:347-54.
      utilizing various versions of MIT-MANUS ro-          BCI Home System (Laboratory of Nervous              8. Latham N, et al. Physical therapy during stroke
                                                                                                                   rehabilitation for people with different walking
      bots for stroke patients is currently underway.      System Disorders, The Wadsworth Center,                 abilities. Arch PM&R 2005; 86:41-50.
                                                           NY State Dept of Health), uses surface elec-        9. Priplata AA, et al. Noise-enhanced balance con-
      Treadmill Devices                                    trodes and software to detect and compile               trol in patients with diabetes and patients with
                                                           EEG signals which patients learn to modu-               stroke. Ann Neurol 2006;59:4-12.
           Several devices combining a treadmill
                                                                                                               10. Volpe B, et al. Is robot-aided sensorimotor train-
      with partial-weight-bearing-support have             late to select characters on a computer screen.         ing in stroke rehabilitation a realistic option? Cur
      been developed over the last 10 years. The           This system has enabled some patients with              Op Neurol 2001;14:745-52.
      Lokomat (Hocoma, Inc., Switzerland) de-              ALS and other severely disabling disorders          11. Serruya MD, Hatsopoulos NG, et al. Instant neu-
                                                                                                                   ral control of a movement signal. Nature
      vice has the added feature of a lower body           to communicate and send email. A
      exoskeleton providing partial assistance for         multicenter trial is being planned to better        12. Hochberg LR, Serruya MD, et al. Neuronal en-
      stepping, and has shown benefit in patients          assess the effectiveness and efficacy of this           semble control of prosthetic devices by a human
      with spinal cord injury. Studies of benefit          system with ALS patients on a larger scale.             with tetraplegia. Nature 2006; 442: 164-71.
      to patients with stroke have been mixed.
      Results of the first study of its use in pa-         CONCLUSIONS                                              Stephen T. Mernoff, MD is Chief,
      tients with multiple sclerosis (Albert Lo,                 Plasticity exists particularly in the post-   Neurology Section, Providence VA Medi-
      MD, PhD) should be available shortly. The            injury period, even in the older population.        cal Center, Clinical Assistant Professor of
      Autoambulator, a similar device developed            Many possible new treatments are being de-          Clinical Neurosciences, The Warren Alpert
      for HealthSouth, is also being studied.              veloped. Particular epochs during the               Medical School of Brown University, Di-
                                                           postinjury period may be windows of oppor-          rector, Neurorehabilitation Program, Re-
      Cortical Stimulation                                 tunity for intervention. Optimization of thera-     habilitation Hospital of Rhode Island, and
            Brain stimulation might enhance neu-           pies for different types of patients is a major     Diplomate, American Board of Psychiatry
      ral plasticity. Noninvasive devices (including       challenge. Ongoing research will determine          and Neurology (Neurolog y).
      Transcranial Magnetic Stimulation and DC             which treatments should be done for which
      Current Stimulation) designed to stimulate           patients, and when. New models of recovery          Disclosure of Financial Interests
      the cerebral cortex during therapy are un-           are under development to enable us to capi-               The author has no financial inter-
      der investigation. A multicenter controlled          talize on advances in neuroscience and tech-        ests to disclose.
      trial is currently underway to determine if          nology to improve rehabilitation outcomes.                Discussion(s) of off-label usage of any
      an epidurally implanted electrode (Northstar               Several landmark studies (recent, on-         products or services: Several devices de-
      Neuroscience), providing subthreshold                going, and upcoming) are demonstrating              scribed in the article are investigational
      stimulation during physical therapy, en-             that neurorehabilitation research is no longer      but are approved by the FDA for inves-
      hances recovery (Spaulding Rehabilitation            in the back reaches of anecdotal evidence           tigational use: devices by Afferent
      Hospital in Boston is a participant).                and unprovable theories. Both low-tech but          Coporation, MIT-MANUS r obot,
                                                           elegant interventions and sophisticated tech-       Locomat, Autoambulator, Northstart
      Brain-Computer Interfaces                            nologies clearly have roles in improving the        device, Braingate (Cyberkinetics, Inc.),
            Patients with severe neurologic disabili-      functioning of patients with both mild and          and Wadsworth BCI Home System.
      ties usually have some residual muscle func-         severe neurologic disabilities, by enhancing
      tion (finger, eyelid, or eye movements) allow-       the nervous system’s natural plasticity. This       CORRESPONDENCE
      ing at least rudimentary communication.              goal is a huge challenge, particularly in the       Stephen T. Mernoff, MD
      Some patients (e.g., ALS, brainstem stroke)          geriatric population. We now have tech-             Providence VA Medical Center, 111N
      are completely paralyzed despite having nor-         niques to perform valid and reliable studies        830 Chalkstone Avenue
      mal or only mildly impaired cognition                of these interventions. Neurorehabilitation         Providence, RI 02908
      (“locked-in”), resulting in inability to com-        is worthy of being considered a medical sub-        Phone: (401) 273-7100x3427
      municate or influence the environment.               specialty subject to the standards of evidence-     e-mail:
      Brain-computer interfaces (BCI) are devices          based medicine.

                        The Value Equation: Costs and Quality of
                              Rhode Island’s Health Plans
                                                            Bruce Cryan, MBA, MS

      Two health plans, Blue Cross and Blue Shield of Rhode Is- ing, treatment, access, and satisfaction). For definitions of these
land (Blue Cross), and United Healthcare of New England measures, see the source report.2 To ascertain relative perfor-
(United), provide health coverage to a large majority of Rhode mance, the measures for each plan are compared to the aver-
Island (RI) residents who are commercially insured. To assess age of all commercial health plans in New England.3
whether the purchasers of these plans’ products are receiving value,
one must necessarily examine its two components, cost and qual- RESULTS
ity. For Rhode Islanders to receive good returns from their expen-        Of Rhode Island’s 342,000 commercially insured popu-
ditures for health insurance, that coverage should be equally or lation, most are covered by two carriers, Blue Cross, with a
less expensive and deliver the same or better quality services than 2006 market share of 64.8%, and United, with a share of
similar plans elsewhere. Information about how these two plans 14.6%. The remainder of the market (20.6%) consists of a
perform is therefore essential to
evaluating their relative value.
      In response to this need for
information, the RI General
Assembly passed the Health
Care Accessibility and Quality
Assurance Act in 1996 (Rhode
Island General Laws 23-
17.13).1 The Act instituted
health plan performance re-
porting in the state, which is
summarized annually, and most
recently in the Rhode Island
Health Plans’ Performance Re-
port (2006).2 The information
presented here is derived from
that report.                            Figure 1. Average health plan premium per member per month, by component, Blue Cross of
                                              Rhode Island, United Healthcare of New England, and New England aggregate, 2006.
      The Rhode Island Depart-
ment of Health’s Center for
Health Data and Analysis con-
ducts an annual health plan data
collection from three primary
audited sources: Statutory Filings
to the state’s Department of Busi-
ness Regulation and Health Plan
Employer Data and Information
Set (HEDIS) reports and Con-
sumer Assessment of Healthcare
Providers and Systems
(CAHPS) survey data submitted
to the Department of Health.3
      From these data, 32 mea-
sures are evaluated, comprising
eight separate dimensions of                Figure 2. Health plan member satisfaction with health plan and health care, Blue Cross of
performance (enrollment, costs,                Rhode Island, United Healthcare of New England, and New England average, 2006.
utilization, prevention, screen-
                                                                                                        VOLUME 91      NO. 5      MAY 2008
                                                                                                 measures are worth examination. For example,
                                                                                                 the low rates of chlamydia screening (Blue
                                                                                                 Cross: 40%; United: 39%) and antidepressant
                                                                                                 medication management (Blue Cross: 26%;
                                                                                                 United: 24%) highlight the need for further
                                                                                                 improvement in these areas.
                                                                                                      Proxy measures of whether members per-
                                                                                                 ceive value in their plans may be obtained from
                                                                                                 member satisfaction surveys. Member satisfac-
                                                                                                 tion with Blue Cross’ performance as a health
                                                                                                 plan was 4 percentage points higher than the
                                                                                                 regional rate in 2006 (69% versus 65%), while
                                                                                                 member satisfaction with United was 15 percent-
                                                                                                 age points below that comparable (50% versus
                                                                                                 65%). (Figure 2) There was little difference in
                                                                                                 members’ satisfaction with their healthcare ser-
                                                                                                 vices between the two plans and in comparison
                                                                                                 with the New England rate. Interestingly, re-
                                                                                                 gardless of geographic area or health insurer,
                                                                                                 more members were satisfied with their
                                                                                                 healthcare services than with their health plans.

                                                                                                   Increasingly, the public, purchasers, pro-
                                                                                              viders, and policymakers are requiring mean-
                                                                                              ingful information about health plans. Since
                                                                                              1998, the Department of Health has tracked
                                                                                              the performance of this industry and produced
                                                                                              annual reports on the subject.2
                                                                                                   With the small number of health plans
                                                                                              in the state and the market dominance of
                                                                                              Blue Cross, most Rhode Islanders have lim-
      number of smaller plans, none of which are domiciled in Rhode        ited choice of carrier. The lack of widespread selective con-
      Island. [Note that these data include only the insurers’ “fully-     tracting also means that most plans deliver services through a
      insured” members and exclude members of plans where the              similar network of physicians, hospitals, and other providers,
      purchaser (employer) is self-insured.]                               and the lack of differentiation between the two plans in their
           On average in 2006, commercial health insurance cost            healthcare satisfaction rates bears this out.
      slightly less in RI than in New England. (Figure 1) Blue Cross’            Therefore, the real value in publishing this information is
      monthly premiums were 2% lower than regional premiums                less in aiding consumer choice and more in fostering account-
      ($317 vs. $325), and United’s premiums were 6% lower                 ability of the industry. Purchasers deserve to know how well
      ($305 vs. $325). In addition, both RI plans spent relatively         the plans are performing and policymakers need empirical evi-
      less on medical services for their members (2% less for Blue         dence to inform their efforts. An added benefit is that the
      Cross and 15% less for United).                                      performance of health plans will likely improve if for no other
           With few exceptions, both Blue Cross and United gener-          reason than the results are made public.
      ally performed at or below average when their clinical quality
      measures were compared to the New England values. (Table                   Bruce Cryan, MBA, MS, is a Health Policy Analyst in the Cen-
      1) For Blue Cross, 12 of its 20 quality measures were equiva-        ter for Health Data and Analysis, Rhode Island Department of Health.
      lent to the regional averages, one measure was better, and the
      remaining seven were worse than these comparables. For               Disclosure of Financial Interests
      United, nine of its 20 quality measures were equivalent to the            The author has no financial interests to disclose.
      regional averages, two measures were better, and the remain-
      ing nine were worse than these comparables. Given that New           REFERENCES
      England health plans consistently post some of the highest qual-     1. See
                                                                           2. Cryan B. Rhode Island Health Plans’ Performance Report 2006. Providence RI:
      ity (and satisfaction) scores in the country, this regional com-
                                                                              Rhode Island Department of Health and Office of the Health Insurance Com-
      parison provides a rigorous benchmark for RI plans.                     missioner. In press.
           In addition to an individual plan’s relative performance on     3. For information on the HEDIS and CAHPS programs, see the website of the
      the clinical measures, the absolute values on some of the clinical      National Committee for Quality assurance (NCQA) -

                                                                                                              DAVID GIFFORD, MD, MPH, DIRECTOR OF HEALTH
                                                               RHODE ISLAND DEPARTMENT   OF   HEALTH                         E DITED BY JOHN P. FULTON, PHD

          Rhode Island Leads In Regulating Office-Based Cosmetic Surgery
                                                                 Shaun Najarian

A recent decision by the Rhode Island Director of Health                     range of output – and the potential for lasers to do irreparable
to close an unlicensed ambulatory surgery center and to sus-                 harm to a patient if used incorrectly. Thus, in Rhode Island, indi-
pend the medical license of the owner underscores the need                   viduals who wish to perform any of these cosmetic laser surgeries in
for the appropriate regulation of cosmetic surgery.                          an office setting must apply for a special license.
      In September 2007, the Rhode Island Department of Health                    In December 2003, the Rhode Island Board of Medical
(HEALTH) closed an ambulatory surgery center owned and oper-                 Licensure and Discipline strengthened its regulatory position
ated by a physician licensed in the State of Rhode Island after the          on the use of medical lasers with the following decision:
Rhode Island Board of Medical Licensure and Discipline (“the
Board”) concluded that the owner/operator had performed a vari-                   12/15/2003 - Policy statement on office based esthetic
ety of cosmetic surgeries in an unlicensed outpatient facility. As well,          procedures:
the Board concluded that the physician had allowed unqualified                    It is the position of the Board that office based cosmetic or
employees to deliver anesthesia to patients at the facility.                      esthetic procedures that require the use of medical lasers, high-
      Public Health is invested in the accreditation, licensure, and              frequency radio waves, or injection of sclerosing chemicals or
regulation of physicians, surgeons and their facilities. Many states              biologically active compounds [e.g. Botulinum toxin A, Botox]
                                                                                  are medical procedures.
have considered legislation regarding the licensure and regulation
of office-based surgery, but few have followed though. At present,                Therefore, prior to undergoing such procedures patients must
only six states have statutes of this type in place: Rhode Island, Cali-          receive a medical evaluation for appropriateness by a licensed
fornia, Florida, New Jersey, Pennsylvania, and Texas.1 In Rhode Is-               and qualified physician or other practitioner acting within
                                                                                  his/her scope of practice. Although these procedures may be
land, legislation was passed in 1999 requiring physicians to be spe-
                                                                                  performed by an appropriately trained nonphysician working
cially licensed by HEALTH in order to perform office-based sur-                   under the supervision and direction of a physician or other
gery, and in 2001, the law was amended, requiring that the facilities             practitioner acting within his/her scope of practice, it is the
be accredited for Level II and Level III anesthesia (intravenous and              supervising physician’s [or other practitioner acting within his/
general) within 24 months of licensure.2 To ensure the highest level              her scope of practice] responsibility to assure that procedures
of patient safety, all states should consider similar legislation.                are conducted appropriately; with appropriate assessment, con-
      Under Rhode Island law, as specified by “Rules and Regu-                    sent and follow-up; and upon appropriate patients; and that
                                                                                  all patient records are maintained according to standards ap-
lations for the Licensure of Physician Ambulatory Surgery Cen-
                                                                                  plicable for medical records; and that patient privacy is pro-
ters and Podiatry Ambulatory Surgery Centers (R23-17-PASC),”                      tected. The supervising physician or other practitioner acting
surgery is defined as follows:                                                    within his/her scope of practice is responsible for any proce-
                                                                                  dures carried out by nonphysicians under his/her direction.
     1.21 “Surgery” means the excision or resection partial/com-
                                                                                  Physicians [or other practitioner acting within his/her scope of
     plete, destruction, incision or other structural alteration of
                                                                                  practice] who perform and supervise such procedures must be
     human tissue by any means. Surgery shall have the same
                                                                                  able to demonstrate appropriate training and experience. Such
     meaning as “operate.”
                                                                                  training and experience may include, but is not limited to, resi-
     Certain procedures are exempt from R23-17-PASC:                              dency or fellowship. The physician or other practitioner acting
                                                                                  within his/her scope of practice is responsible to assure and docu-
     1.8 “Exempt procedures” means: a) Minor surgical proce-
                                                                                  ment adequate training for individuals under his/her supervision.
     dures such as excision of skin lesions, moles, warts, lipomas
     and repair of lacerations, incision and drainage of superficial              Additionally, other cosmetic procedures such as dermabrasion or
     abscesses, or surgery limited to the skin and subcutaneous                   the application of potentially scarring chemical treatments [e.g.
     tissue performed under topical or local anesthesia not in-                   so-called chemical peels] should also meet this same standard.
     volving drug induced alteration of consciousness other than
                                                                                  [Rhode Island Board of Medical Licensure and Discipline. “Policy
     minimal pre-operative tranquilization of the patient; b) Pro-
                                                                                  statement on office based esthetic procedures.” December 15,
     cedures not requiring or using conscious sedation techniques
     or pre-operative medications other than minimal pre-opera-                   2003.]
     tive tranquilization of the patient; c) Procedures requiring or
     using only local, topical, or no anesthesia.”                                Despite increased vigilance such as this, office-based laser
                                                                             hair removal remains especially troublesome to regulate
     All medical laser procedures fall under the aegis of the Rhode          throughout the United States. Many unlicensed facilities per-
Island statute, including ablative and non-ablative skin rejuvena-           form the work, unaware of potential dangers and of existing
tion procedures, tattoo removals, treatment of pigmented and vas-            safety regulations, e.g., those that limit maximum laser expo-
cular lesions, and laser hair removal. The reason for regulating all         sure or require eye protection. At least one death in the United
medical laser procedures, including laser hair removal, is the sheer         States has been attributed to an overdose of anesthetic cream
variety (and changing variety) of laser devices – including a wide           before laser hair removal.3
                                                                                                                 VOLUME 91         NO. 5      MAY 2008
           Several national organizations seek to improve the quality               of a service provider may consult HEALTH’s website: http://
      of office-based surgical practices:                                 
      • The American Association for Accreditation of Ambu-                         REFERENCES
        latory Surgery Facilities (AAAASF)                                          1. Lapetina EM, Armstrong EM. Preventing errors in the outpatient setting.
      • The Accreditation Association for Ambulatory Health                            Health Affairs 2002; 21: 28.
        Care (AAAHC)                                                                2. Springer R. An update on office surgical regulations. Plastic Surgical Nurs
                                                                                       2004;24: 172.
      • The Joint Commission for Accreditation of Healthcare
                                                                                    3. On February 18, 2005, National Public Radio’s (NPR’s), Adam Hochberg dis-
        Organizations (JCAHO)                                                          cussed the dangers of an unregulated laser industry on his show “All Things Consid-
                                                                                       ered.” Hochberg reported on the case of a North Carolina woman who died from an
           The JCAHO recently released safety goals for office-based                   overdose of anesthetic cream that she applied before her laser treatment in January.
           Despite the best efforts of HEALTH, some health profes-                      Shaun Najarian is an undergraduate at Providence College
      sionals may continue to perform cosmetic surgical procedures in               who served as an intern for the Rhode Island Department of
      unlicensed facilities. It is important for healthcare providers               Health, Office of Medical Licensure and Discipline.
      throughout the state to be vigilant for this possibility. At present,
      in addition to licensed hospitals and licensed freestanding surgi-            Disclosure of Financial Interests
      cal centers, only five “office operatories” are licensed in Rhode                   The author has no financial interests to disclose.
      Island. Those who wish to verify the license status of a facility or

      Point of View
       Creative and Sensory Therapies Enhance the Lives of People With Alzheimers
                                                                     John Stoukides, MD
      Today physicians have access to an enormous body of research                        Although treatment is not available today that can delay or
      and knowledge regarding the pathophysiology of Alzheimer’s dis-               stop the deterioration of brain cells in Alzheimer’s disease, studies
      ease. Pharmacologic treatment options have also increased signifi-            have consistently shown that active medical management of
      cantly over the past few years. However, pharmacologic treatment              Alzheimer’s and other dementias can significantly improve quality
      is only one part of the overall care plan for improving the quality of        of life through all stages of the disease for diagnosed individuals
      life of patients suffering from Alzheimer’s and related dementias.            and their caregivers. Active medical management includes the inte-
            Long-term care facilities and adult day centers throughout Rhode        gration of support services like adult day services that offer creative
      Island use a variety of creative and sensory therapies to enhance the lives   and sensory therapies into the overall treatment plan.
      of people with Alzheimer’s including aromatherapy and massage; paint-               Most of the participants in the Hope Center’s art therapy pro-
      ing, pottery, sculpting; music and dance; exercise and cooking.               gram live at home, where they are cared for by family and friends.
            The “Memories Fade…Love Inspires” art exhibit, recently held at         Even when care is provided at home, most families also seek other
      the Bellini Ruggeri Gallery in Providence, showcased a collection of          sources of help, particular as the disease progresses. As a trusted
      watercolor paintings and pottery pieces created by participants at the        information source for family caregivers, physicians can discuss the
      Hope Alzheimer’s Center. The cover of this journal features the beau-         benefits of choosing an adult day program or long-term care pro-
      tiful work of Theresa Aiello, a long time participant in the therapeutic      vider that offers creative and sensory therapies for people with
      art program at the Hope Center. Although Theresa, age 91, has had no          Alzheimer’s and other forms of memory loss.
      formal art training, she is able to express herself through vivid color
            Since opening its doors in 1995, art therapy has been a center-             John Stoukides, MD, is Medical Director of the Rhode Island Mood
      piece of the adult day program at the Hope Center. Through the                & Memory Research Institute and Director of Geriatric Medicine at
      years, the Center has reported seeing many withdrawn and quiet                Roger Williams Medical Center.
      participants begin to engage in lively conversations about a special
      place or time in their life reflected in the painting.                        Disclosure of Financial Interests
            Research conducted in the field of Alzheimer’s shows clear evi-               The author has no financial interests to disclose.
      dence that art therapy is a powerful, nonmedical way to engage
      minds in the grip of this disease. For people with memory loss,               CORRESPONDENCE
      creative and sensory activities can help:                                     John Stoukides, MD
         Promote well being               Help maintain skills
         Aid communication by             Enhance relationships
            using sensory rather          Utilize past skills
            than cognitive pathways       Express emotion
         Facilitate decision making       Encourage cooperation
         Combat depression                  with others
                            Physician’s Lexicon
                                                          The Prefixes of the Past

The prefix, particularly when employed              pallidus] and Paleocene [the geologic ep-               ing the appreciation of vibration, is from
for the technical terms such as those which         och preceding the Eocene.] Palin-, in                   the Greek, pallo, meaning to quiver.
serve medicine, informs us about the root           Greek meaning backwards, appears in                           The Greek prefix, presby-, meaning ven-
of the noun: its size [eg, macro-, micro-,], its    words such as palindrome [a word or                     erable or ancient, is seen in words such as pres-
spatial relationship [eg, juxta-, infra-, supra-    phrase reading the same backward or for-                byopia, presbycusis, an older euphemism for
], as well as an array of attributes to define      ward], palingenesis [meaning regeneration               deafness, and Presbyterian. The Latin prefix,
for us more precisely the modified mean-            or rebirth] and palinopsia [a recurrent vi-             pretero-, meaning coming before or beyond,
ing of the root word. A special group of            sual disorder.]                                         appears in words such as preternatural [a syn-
prefixes, either Latin or Greek, also tells us           The pal- prefix such as in palinopsia,             onym for supernatural] and preterition.
whether or not the noun is old, ancient,            however, can be confusing. Palisade, for                      Medical terms beginning with the
backwards or primitive. These prefixes in-          example, is derived from the Latin word,                Latin prefixes pro- and pre- are too numer-
clude the following: ante-, paleo-, palin-,         palus, meaning a stake. Palliation, mean-               ous to list. Precocity, for example, is from
pre-, presby-, pretero- and proto-.                 ing to extenuate, to cloak [and, specifically,          the Latin praecox, meaning to ripen early,
      Ante-, Latin signifying before or prior       to lessen pain] comes from the Latin, pal-              thus explaining the phrase, dementia prae-
to, is seen in words such as antecubital and        lium, meaning a cloak. Pallid, meaning                  cox, an older term for schizophrenia. Pre-
antenatal [but not antigen or antacid.]             ashen or pale, is from the Latin, pallidus,             cipitation is from the Latin, praecipitare,
Paleo-, from the Greek meaning primitive            meaning pale or colorless [as in globus                 meaning to cast down headlong, and ulti-
or ancient, appears in such technical terms         pallidus.] Paludism, an archaic name for                mately derives from capitus, meaning head.
as paleopathology, paleontology, paleo-             malaria, is from the Latin, palus, meaning
striatum [a synonym for the globus                  marsh or swamp. And pallesthesia, mean-                                   – STANLEY M. ARONSON, MD

                D AVID GIFFORD, MD, MPH
                                                                                            V I TA L S TAT I S T I C S
                DIRECTOR OF HEALTH                                                                    EDITED BY C OLLEEN FONTANA, STATE REGISTRAR

                                                        Underlying                                              Reporting Period
 Rhode Island Monthly                                 Cause of Death                             May
                                                                                                                  12 Months Ending with May 2007
 Vital Statistics Report                                                                     Number (a)     Number (a)             Rates (b)           YPLL (c)
Provisional Occurrence                                   Diseases of the Heart                        223          2,730               255.2          3,601.5
                                                        Malignant Neoplasms                           201          2,261               211.4          6,077.5
     Data from the                                  Cerebrovascular Diseases                           36            388                36.3            562.0
Division of Vital Records                            Injuries (Accidents/Suicide/Homicde)              43            565                52.8          9,003.0
                                                                                 COPD                  50            434                40.6            392.5

                                                          Reporting Period                                  (a) Cause of death statistics were derived from

      Vital Events                          November               12 Months Ending with
                                                                                                            the underlying cause of death reported by
                                                                                                            physicians on death certificates.
                                              2007                    November 2007
                                                                                                            (b) Rates per 100,000 estimated population of
                                              Number                Number                   Rates
                         Live Births               942              13,521                   12.7 *
                             Deaths                826               9,943                    9.3*          (c) Years of Potential Life Lost (YPLL)
                    Infant Deaths                   (9)              (108)                    8.0#
                  Neonatal Deaths                   (6)                (74)                   5.5#          Note: Totals represent vital events which occurred in Rhode
                    Marriages                      394               6,879                    6.4*          Island for the reporting periods listed above. Monthly pro-
                     Divorces                      187               3,026                    2.8*          visional totals should be analyzed with caution because the
                                                                                                            numbers may be small and subject to seasonal variation.
         Induced Terminations                      386               4,919                  363.8#
     Spontaneous Fetal Deaths                       49                 994                   73.5#          * Rates per 1,000 estimated population
       Under 20 weeks gestation                    (45)              (920)                   68.0#          # Rates per 1,000 live births

           20+ weeks gestation                      (4)                (74)                   5.5#
                                                                                                                        VOLUME 91           NO. 5       MAY 2008
                                The Official Organ of the Rhode Island Medical Society
                          Issued Monthly under the direction of the Publications Committee
            VOLUME 1                                                                    PER YEAR $2.00
            NUMBER 1     PROVIDENCE, R.I., JANUARY, 1917                        SINGLE COPY, 25 CENTS

      NINETY   YEARS AGO,     MAY, 1918                                            FIFTY YEARS AGO, MAY 1958
           Frank J. McCabe, MD, in “Eye Strain as Related to Gen-                       Eugene T. Lothgren, MBA, general agent, Northwestern
      eral Practice,” discussed types of asthenopia: accommodative,                Mutual Life Insurance Company, contributed “Tax Savings in
      “due to errors of refraction and to strain of the…muscle;”                   Estate Planning for Physicians.” He urged: “action is essential
      muscular, “due to an abnormal condition of the…muscles of                    to security and peace of mind.”
      the eye;: nervous, “due to some faulty condition of the nervous                   The Division of Vital Statistics of the Rhode Island De-
      system;” and reflex, “due to abnormalities in the organism out-              partment of Health contributed “Acute Poliomyelitis in Rhode
      side of the eye and the nervous system.” Accommodative strains               Island, 1948-57.” Many Americans, including Rhode Island-
      were the most common.                                                        ers, were not yet vaccinated. “Unless there is a speedup in the
           Frederick V. Hussey, MD, in “A Review of 100 Consecu-                   polio vaccination program it is the opinion of the Surgeon Gen-
      tive Cases of Acute Diseases of the Appendix, Gall Bladder,                  eral, Leroy E. Burney, that serious outbreaks of poliomyelitis
      Duodenal and Gastric Ulcers Which Have Come to Opera-                        could occur this summer.” The State traced wide fluctuations
      tion,” faulted general physicians’ “lack of courage – reluctance             in incidence: in 1948, 8 cases; in 1949, 157 cases; in 1950, 55
      to advise radical measures in the beginning, without first try-              cases; in 1951, 15 cases. The toll rose to 295 in 1953, dropped
      ing out some of the older methods of treatment, which brings                 to 123 in 1954, peaked at 421 in 1955.
      his patient into an extreme condition.” The author conceded                       Robert W. Hyde, MD, in “Butler Health Center Today,”
      that often patients wanted to avoid surgery. Of 46 cases of acute            described the 1957 reorganization of Butler Hospital into a
      gangrenous appendicitis, all drained, three died; the average                Health Center, with outpatient and day services.
      hospital length of stay for those patients was 3 weeks.                           David S. Liang, MD, and Asdrubal De Carvalho, MD, in
           In a War Department memo, the Office of the Surgeon                     “Leiomyoma of the Prostate,” described an 87 year-old man,
      General, Washington, reminded physicians of the rule forbid-                 admitted to Joseph’s with “painful gross hematuria for 2 days.”
      ding publication of professional papers related to official                  Surgeons found and removed an intravesical tumor.
      records or military service, without permission.                                  Bencel L. Schiff, MD, in “Dermatitis from Acetozolamide
           An editorial, “Illegal Operations,” described the case of a             (Diamox),” discussed the case of a 45 year-old woman who
      woman recently convicted of an “illegal operation.” “The                     had been given 250 mg daily for treatment of glaucoma, and
      woman had enjoyed a lucrative clientele for some time, pursu-                the case of a 57 year-old man, treated for hypertension and left
      ing her work in a respectable residential section of Providence.”            ventricular failure.
      The editor assumed that this was the first case of a woman con-
      victed in Rhode Island for the “crime of performing abortions,               TWENTY-FIVE YEARS AGO, MAY 1983
      and, furthermore, … the conviction did not depend upon the                        Carl H. Critz, MD, W. Martin DeLuca, PA, and Arun K.
      death of the unfortunate patient.” The editorial congratulated               Singh, MD, in “Iatrogenic Extra-Corporeal Hemolysis during
      both the police and the Attorney General. “…decent public                    Cardiac Surgery in a Child: A Case Report,” postulated “shear-
      opinion cannot fail to approve of the outcome.”                              stress in transfusion filter as the cause of the hemolysis.” A four
                                                                                   year-old girl had been admitted to Rhode Island Hospital for
                                                                                   surgical correction of both an atrial septal defect and pulmo-
                                                                                   nary valvular stenosis.
                                                                                        Frank Newman, PhD, President, The University of Rhode
                                                                                   Island, delivered the 1982 Fiorindo A. Simeone oration at The
                                                                                   Miriam Hospital: “Notes from Underground.” His subject was
                                                                                   the anatomy of recovery. He detailed his experience of hospi-
                                                                                   talization, including “coping with fear,” and “role of the self in
                                                                                        A.J. Migliaccio, MD, FACS, and A.V. Migliaccio, MD,
                                                                                   FACS, contributed “The Use of a Feeding Gastrostomy as a
                                                                                   Means of Preventing Staple Line Disruption in Gastric Opera-
                                                                                   tions for Morbid Obesity.”



         Whatever it is that sustains you through the daily challenges
         of your profession, know that you have an ally in NORCAL.

                         (800) 652-1051   ●

Call RIMS Insurance Brokerage Corporation at (401) 272-1050 to purchase NORCAL coverage.

To top